AU7509194A - Production and application of transgenic mushroom mycelium and fruitbodies - Google Patents
Production and application of transgenic mushroom mycelium and fruitbodiesInfo
- Publication number
- AU7509194A AU7509194A AU75091/94A AU7509194A AU7509194A AU 7509194 A AU7509194 A AU 7509194A AU 75091/94 A AU75091/94 A AU 75091/94A AU 7509194 A AU7509194 A AU 7509194A AU 7509194 A AU7509194 A AU 7509194A
- Authority
- AU
- Australia
- Prior art keywords
- dna
- host
- transformed
- transformation
- homobasidiomycete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000009261 transgenic effect Effects 0.000 title claims description 30
- 238000004519 manufacturing process Methods 0.000 title claims description 27
- 235000001674 Agaricus brunnescens Nutrition 0.000 title description 25
- 108020004414 DNA Proteins 0.000 claims description 167
- 238000000034 method Methods 0.000 claims description 111
- 230000009466 transformation Effects 0.000 claims description 97
- 210000001938 protoplast Anatomy 0.000 claims description 84
- 101150047832 hpt gene Proteins 0.000 claims description 74
- 239000013612 plasmid Substances 0.000 claims description 74
- 239000012634 fragment Substances 0.000 claims description 60
- 230000013011 mating Effects 0.000 claims description 60
- 239000013598 vector Substances 0.000 claims description 60
- 239000000463 material Substances 0.000 claims description 59
- 239000002609 medium Substances 0.000 claims description 58
- 108090000623 proteins and genes Proteins 0.000 claims description 51
- 239000003550 marker Substances 0.000 claims description 49
- 241000009794 Agaricomycetes Species 0.000 claims description 44
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 claims description 35
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 claims description 35
- 229940097277 hygromycin b Drugs 0.000 claims description 35
- 230000015572 biosynthetic process Effects 0.000 claims description 34
- 230000010354 integration Effects 0.000 claims description 29
- 230000012010 growth Effects 0.000 claims description 27
- 229920001817 Agar Polymers 0.000 claims description 26
- 241000588724 Escherichia coli Species 0.000 claims description 26
- 239000008272 agar Substances 0.000 claims description 26
- 150000007523 nucleic acids Chemical class 0.000 claims description 21
- 230000004927 fusion Effects 0.000 claims description 19
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 18
- 229930024421 Adenine Natural products 0.000 claims description 18
- 238000004458 analytical method Methods 0.000 claims description 18
- 108020004707 nucleic acids Proteins 0.000 claims description 18
- 102000039446 nucleic acids Human genes 0.000 claims description 18
- 210000004940 nucleus Anatomy 0.000 claims description 18
- 230000008929 regeneration Effects 0.000 claims description 18
- 238000011069 regeneration method Methods 0.000 claims description 18
- 229960000643 adenine Drugs 0.000 claims description 17
- 238000004520 electroporation Methods 0.000 claims description 17
- 230000003111 delayed effect Effects 0.000 claims description 15
- 230000014509 gene expression Effects 0.000 claims description 15
- 230000002068 genetic effect Effects 0.000 claims description 14
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 13
- 230000004069 differentiation Effects 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 230000003716 rejuvenation Effects 0.000 claims description 12
- 230000003115 biocidal effect Effects 0.000 claims description 10
- 238000002955 isolation Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 8
- 230000001747 exhibiting effect Effects 0.000 claims description 8
- 108091081024 Start codon Proteins 0.000 claims description 7
- 238000010367 cloning Methods 0.000 claims description 7
- 230000007812 deficiency Effects 0.000 claims description 7
- 230000001131 transforming effect Effects 0.000 claims description 7
- 230000014621 translational initiation Effects 0.000 claims description 7
- 241000221198 Basidiomycota Species 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 101100120909 Caenorhabditis briggsae gpd-3.2 gene Proteins 0.000 claims description 5
- 101100120910 Caenorhabditis elegans gpd-2 gene Proteins 0.000 claims description 5
- 108010044467 Isoenzymes Proteins 0.000 claims description 5
- 108091026890 Coding region Proteins 0.000 claims description 4
- 230000003872 anastomosis Effects 0.000 claims description 4
- 210000000349 chromosome Anatomy 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 230000003292 diminished effect Effects 0.000 claims description 4
- 239000006870 ms-medium Substances 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 3
- 239000000417 fungicide Substances 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims 1
- 238000009877 rendering Methods 0.000 claims 1
- 238000002105 Southern blotting Methods 0.000 description 39
- 239000000523 sample Substances 0.000 description 39
- 239000000047 product Substances 0.000 description 29
- 241000351920 Aspergillus nidulans Species 0.000 description 21
- 230000029087 digestion Effects 0.000 description 19
- 108060001084 Luciferase Proteins 0.000 description 17
- 229930006000 Sucrose Natural products 0.000 description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 17
- 239000005720 sucrose Substances 0.000 description 17
- 238000007429 general method Methods 0.000 description 16
- 101710111073 External scaffolding protein D Proteins 0.000 description 13
- 239000002299 complementary DNA Substances 0.000 description 13
- 239000002361 compost Substances 0.000 description 13
- 108091008146 restriction endonucleases Proteins 0.000 description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 12
- 229920000298 Cellophane Polymers 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 241000222481 Schizophyllum commune Species 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 230000000295 complement effect Effects 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 210000002421 cell wall Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000005089 Luciferase Substances 0.000 description 8
- 238000000636 Northern blotting Methods 0.000 description 8
- 102000027549 TRPC Human genes 0.000 description 8
- 108060008648 TRPC Proteins 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 241000701959 Escherichia virus Lambda Species 0.000 description 7
- 101150001038 ade gene Proteins 0.000 description 7
- 230000000692 anti-sense effect Effects 0.000 description 7
- 230000002538 fungal effect Effects 0.000 description 7
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 6
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 6
- 108010035235 Phleomycins Proteins 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 101150038738 ble gene Proteins 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000011426 transformation method Methods 0.000 description 6
- 244000251953 Agaricus brunnescens Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 241000222518 Agaricus Species 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 4
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 240000000599 Lentinula edodes Species 0.000 description 4
- 238000010222 PCR analysis Methods 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 230000001594 aberrant effect Effects 0.000 description 4
- 235000009120 camo Nutrition 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 235000005607 chanvre indien Nutrition 0.000 description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000011487 hemp Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 230000000644 propagated effect Effects 0.000 description 4
- 238000005204 segregation Methods 0.000 description 4
- 238000013207 serial dilution Methods 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101710091977 Hydrophobin Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 241000254058 Photinus Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XHLUWCXVWCBOPP-MERQFXBCSA-N (2s)-1-(2-aminoacetyl)-n-(4-nitrophenyl)pyrrolidine-2-carboxamide;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.NCC(=O)N1CCC[C@H]1C(=O)NC1=CC=C([N+]([O-])=O)C=C1 XHLUWCXVWCBOPP-MERQFXBCSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 101001009678 Homo sapiens Glycerol-3-phosphate dehydrogenase, mitochondrial Proteins 0.000 description 2
- 108091029795 Intergenic region Proteins 0.000 description 2
- 241000254158 Lampyridae Species 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101100108644 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alo-1 gene Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 241000203644 Streptoalloteichus hindustanus Species 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XYIPYISRNJUPBA-UHFFFAOYSA-N [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC(C3)CC2C4)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 XYIPYISRNJUPBA-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 230000012361 double-strand break repair Effects 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 101150073906 gpdA gene Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 238000007852 inverse PCR Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000004983 pleiotropic effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000007285 sdo medium Substances 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000070268 Agaricus arvensis Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000023514 Barrett esophagus Diseases 0.000 description 1
- 101100268670 Caenorhabditis elegans acc-3 gene Proteins 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical group C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 206010056740 Genital discharge Diseases 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 102100036669 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Human genes 0.000 description 1
- 102100030395 Glycerol-3-phosphate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101001072574 Homo sapiens Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- BCXBIONYYJCSDF-CIUDSAMLSA-N Ile-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O BCXBIONYYJCSDF-CIUDSAMLSA-N 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 108020000290 Mannitol dehydrogenase Proteins 0.000 description 1
- PBOUVYGPDSARIS-IUCAKERBSA-N Met-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C PBOUVYGPDSARIS-IUCAKERBSA-N 0.000 description 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241001079660 Phanes Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000204715 Pseudomonas agarici Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 241000009791 Tremellomycetes Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000301083 Ustilago maydis Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108010090409 novozym 234 Proteins 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000000485 pigmenting effect Effects 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000822 sequential centrifugation Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
- C12N15/04—Fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immunology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Title: PRODUCTION AND APPLICATION OF TRANSGENIC MUSHROOM MYCELIUM AND FRUITBODIES.
FIELD OF THE INVENTION The invention involves different methods to modify genetic charac¬ teristics of homobasidiomycetes in particular commercial homobasidio¬ mycetes such as the common or button mushroom Agaricus bispovus via treatment with donor DNA or fusions using protoplasts and via matings between strains. The methods may be used for the improvement of com- mercial characteristics and for the commercial production of enzymes and metabolites.
BACKGROUND OF THE INVENTION
Fruitbodies from the common or button mushroom A. bispovus (Lange Imbach) , also denoted A. bτunnescens belonging to the class of basidiomycetes (order Agavicales) , constitute an important crop in the Netherlands with a production of 190 million kilos in 1992. Almost 75 of this crop is exported. The United States of America, China and France are other important mushroom producing nations. General problems associated with the production and keeping of mushrooms involve e.g. infections by pathogens like Pseudomonas tolaasi i or P. agarici , dsRNA viruses and browning caused by the action of endogenous poly-phenol-oxidases (PPO, like tyrosinase) . To further improve product quality, conventional breeding programmes already carried out have been only moderately successful and may appear not to be sufficient on the long run, because this procedure is highly time consuming and because the genetic variation in commercially available strains is limited (Horgen et al. 1991) •
The main problem for effective breeding strategies is caused by the rather abnormal life-cycle of A. bispovus , which involves the usual simul- taneous segregation of either parental nucleus into one basidiospore. After outgrowth of this basidiospore heterokaryotic mycelium is formed containing nuclei and genetic characteristics that do not differ from those present in the parental mycelium. In addition, only little recombi- national activity is observed during meiosis (Summerbell et al. 1989) • For this reason investigators all over the world have attempted for quite some years to develop a transformation system for commercial mush¬ rooms such as A. bispovus for the introduction of novel characteristics. In other organisms, especially in plants the application of gene transfer technology is quite common and has already resulted in the first commer-
cial applications, but the absence of a transformation system generally applicable in a wild-type background in many basidiomycetes has strongly hampered molecular-biological research of such organisms, especially that of edible mushrooms. Contrary to the situation in many ascomycetes, the application of antibiotic resistance markers for dominant selection of transformants of basidiomycetes has to date only been moderately successful. As a repre¬ sentative for heterobasidiomycetes, the phytopathogenic fungus Usti lago maydis has been reported to be transformable with both auxotrophic and antibiotic-resistance markers (Wang et al. 1988) .
Within the class of homobasidiomycetes to which also edible mush¬ rooms like A. bispovus and Pleuvotus ostveatus (oyster mushroom) belong, Schizophyllum commune is considered a model organism to study genetics and developmental biology (Raper 1988) . S. commune is in fact one of the first representatives of this class for which a transformation system was developed. This system is based on complementation of a tvpl auxotroph with the homologous TRP1 gene (Munoz-Rivas et al. 1986) . However, it does not offer the possibility to transform non-auxotrophic homobasidio¬ mycetes. So far, donor DNA comprising a prokaryotic dominant selection marker has not yet been found both integrated and expressed at a level which allows direct selection and stable maintenance of transformed homobasidiomycetes.
Successful transformations with auxotrophic markers have been described for S. commune (Munoz-Rivas et al. 1986) , Copvinus cineveus (Binninger et al. 1987) and Phanevochaete chvysospovium (Alic et al 1989). In P. chvysospovium (Randall and Reddy 1992) and P. ostveatus (Peng et al. 1992) selection with antibiotic resistance markers was recently described, however the donor DNA sequences were not found to be integrated into the recipient genome and were subject to methylation. Peng et al describe the use of recombinant plasmid pAN7-l for transformation with resistance to hygromycin B as selectable marker in P. ostveatus.
Similar processing of donor DNA was also observed in S. commune where the heterologous E. coli hpt (hygromycin B phosphotransferase) gene was introduced as antibiotic selectable marker by co-transformation in an auxotrophic strain of S. commune (Mooibroek et al. 1987). The heterologous sequences appeared to be heavily methylated, which may explain the low level of their expression (Mooibroek et al. 1990) and thus the difficulty to retrieve transformants by direct hygromycin B selection. It was
necessary to first select transformants for their ability to overcome the auxotrophic deficiency and subsequently to detect amongst those trans¬ formants a subset having hygromycin B resistance. The reverse selection, i.e. first for hygromycin B resistance did not produce results presumably due to low expression of the heterologous DNA and the consistent genera¬ tion of false positive colonies that escaped the selective pressure but were not transformed. Similarly it was also suggested for A. bispovus that methylation of donor DNA or the low level of recombination in this orga¬ nism might be causative for its resistance to genetic transformation (Royer and Horgen 1991)- Despite numerous world-wide attempts, successful transformation of A. bispovus with heterologous DNA (Challen et al. 1991. Royer and Horgen 1991) leading to transformants comprising said DNA stably integrated and/or expressing it sufficiently to be detectable still has not been reported. The numerous unsuccessful attempts have been carried out with various strains (among them the A. bispovus strain Ul) with the hpt-marker already mentioned as well as with other heterologous markers (Challen et al. 1991. Royer and Horgen 1991) • It has been sug¬ gested that other markers should perhaps be included in the transforma¬ tion experiments, e.g. β-glucuronidase (GUS) gene for transient expres- sion (Royer and Horgen 1991)-
All data to date suggest that homobasidiomycetes are reluctant to genetic transformation with heterologous especially prokaryotic dominant selection markers. The results of attempting genetic manipulation of homobasidiomycetes include the perception that this reluctance may be due to insufficient expression and subsequently difficulties in detection of transformants.
One method currently used to obtain genetic variance in mushrooms is protoplast fusion. Teikoku-Pharm's Japanese patent e.g. discloses the preparation of a new strain of mushroom by protoplast fusion of Lentinus edodes and P. ostveatus exhibiting the taste of L. edodes and also exhibit¬ ing rapid growth. This method does not however lead to controlled manipu¬ lation of the characteristics of the resulting hybrid.
In Campbell Soup's US patent 4996390 commercial mushrooms of the genus Agavicus are disclosed containing genetic material from more than one species obtained by protoplast fusion. In particular the auxotrophic A. bitovquis (auxotrophic for nicotinic acid and resistant to cyclo- heximide) and a homokaryotic strain of A. bispovus (auxotrophic for adenine and uracil and resistant to cycloheximide) is described. This hybrid cannot form fruiting bodies, but can be crossed to form another
hybrid. Yet again this is not a method for selectively incorporating one or a few selected genes but is a method for random transfer of genetic material. Furthermore it suggests that auxotrophic species and species already comprising naturally occurring or mutagen induced resistance markers can only be used for efficient selection of hybrids.
DESCRIPTION OF THE INVENTION
Completely surprisingly during work on an A. bispoι~us strain 'Abade' to develop a transformation system based on complementation with the corresponding wild-type gene with a view to later applications in co- transformation systems along the lines of the previously mentioned approach for S. commune (Mooibroek et al. 1990) and A. bispovus transformation (Royer and Horgen 1991) a novel and efficient method of transformation of homobasidiomycetes was developed. As the nature of the deficiency resulting in an adenine requirement and the mutation in the corresponding DNA sequences are unknown and in view of the large amount of work required to isolate the putative comple¬ menting sequence, transformation experiments were first initiated with available vectors containing the E. coli hpt-gene . The efficient transformation of this strain was completely unexpected in view of the fact that despite occasional satisfactory yields of protoplasts from A. bispovus Ul having been achieved, no transformants had previously been detected when using the same vector.
It was even more surprising to ascertain that successful use could be made of the heterologous hpt-marker for transformation of UlmplO, a new protoclone isolated from strain Ul via protoplasting and regenera¬ tion. This strain was selected for its similarity with 'Abade' with respect to early growth characteristics and colony morphology. Although UlmplO yielded fewer protoplasts than 'Abade', strain UlmplO also appeared to be transformable with the hpt-gene, contrary to strain Ul or other protoclones thusfar. These data indicate that the development of the transformation systems now available for 'Abade' and UlmplO could not be anticipated on the basis of current knowledge of A. bispovus transformation. The subject invention is directed at a method for obtaining a selectable stable transformant of a homobasidiomycete capable of expres¬ sing integrated donor DNA comprising at least a dominant selectable marker at a detectable level, wherein said host is optionally non-auxo- trophic and can be transformed without cotransformation with said
dominant selectable marker and said host is transformed with said donor DNA. The method according to the invention can successfully be used on commercial strains of homobasidiomycetes, such as strains belonging to the genus Agavicus . It has thus become possible to produce transgenic mycelium and fruitbodies by the introduction of foreign and/or homologous DNA sequences and the expression thereof resulting in new genetic and/or phenotypic characteristics in said mushroom mycelium and/or fruitbodies. The transgenic mushroom material may also be applied for the transfer of transformed nuclei to mushroom mycelium of the same strain, another strain of the same species, another species of the same family or another species of another family. The transgenic organism or any part thereof may further be used for the production of foreign and/or homologous proteins, (poly)peptides and/or metabolites. The proteins, (poly)peptides and/or metabolites may be recovered from the organism's tissues and/or from the medium. The method may be used for the production of strains with improved quality aspects, such as reduced levels of browning (e.g. PPO-activity) , for the production of pathogen resistant strains and for the genetic marking of commercially interesting strains of mushrooms to establish proprietary rights. It has now become possible to integrate specific desired heterologous nucleic acid sequences in a homobasidiomycete and maintain said nucleic acid sequence in the transformed mycelium and the fruiting body resulting therefrom, without the need for sustained selective pressure.
For the subject specification a dominant selectable marker is meant to be a marker that is selectable in a wild type of the host to be trans¬ formed i.e. a host without auxotrophic deficiencies. It is therefore now possible to transform homobasidiomycetes strains that are not auxotrophic with a selectable marker.
The method of transformation according to the invention in the embodiments just described can in particular be very successfully carried out on a host obtained by subjecting homobasidiomycete material to a transformation procedure, wherein the host to be transformed exhibits delayed differentiation in comparison either to non-protocloned homobasidiomycete material and/or the wild type strain Ul as obtainable from ATCC, said delayed differentiation being macroscopically visible in the form of amended morphology due to a change in the number and/or height of aerial hyphae, preferably by the absence of aerial hyphae and/or by a diminished hyphae aggregate formation preferably by the
absence of hyphae aggregates. In particular a method wherein the host belongs to the strain 'Abade' is an embodiment that provides good results. 'Abade' exhibits delayed differentation when compared to Ul as obtained from ATCC. A strain exhibiting amended morphology of the required type for use in a method of transformation according to the invention can be suitably obtained by subjecting homobasidiomycete material to protocloning followed by selection of resulting homobasidiomycete material exhibiting the desired delayed differentiation. A suitable host can also be obtained by subjecting homobasidiomycete material to a rejuvenation procedure followed by selection of resulting homobasidiomycete material exhibiting the desired delayed differentiation. Preferably the transformation procedure commencing with the protoplast formation is carried out as soon as possible after detection of the occurrence of delayed differentiation. With a view to preventing loss of the transformability of the rejuvenated homobasidiomycete material it is preferable to commence the transformation procedure with the formation of protoplasts using material which has not been subjected to more than 25 outgrowth phases. An outgrowth phase in this respect comprises selecting a colony, plating out the colony and growing the colony on a 9 cm agar plate until the plate is full and a person skilled in the art will recognise that equivalents to the number and length of outgrowth phases thus defined also fall within the scope of the invention. Extremely good results were achieved when less than five outgrowth phases took place between selection of the desired rejuvenated host homobasidiomycete material and protoplast formation as part of the transformation procedure. It is supposed that the transformability can be lost if the number of outgrowth phases is too high.
The good results achieved are in particular illustrated by the results of transformation of the strains 'Abade' and UlmplO with donor DNA comprising a dominant selectable marker in a manner according to the invention. In the description of the experiments a detailed method of transformation of these strains with plasmid DNA comprising the hpt gene as dominant selectable marker is given. To our knowledge no investigations were conducted or attempts undertaken for the description of the 'Abade' flat or thin type of morphology. The morphology of 'Abade' colonies was never observed in any other commercial or non-commercial strain of A. bispovus, except shortly after protoplasting and regeneration on CMPS-medium. On different media tested, including MMP, CMP, DTδO, MS
and B5, it has a brownish to light-brown, translucent appearance, lacking any macroscopically visible aerial hyphae emerging from the main colony which is attached to the agar medium, nor does it show any aggregation of hyphae. The different morphology was apparent directly after purchase from the ATCC strain collection. The 'Abade' morphology shows resemblance with the phenotypes described e.g. for S. commune thn (thin) mutants (Wessels et al., 1991a) • n the thn mutant described the expression of the Sc3-nydrophobin gene is blocked as well as the generation of aerial hyphae. It has been suggested that hydrophobins accumulate in the cell walls of the hyphae that excrete them and contribute to the formation of hydrophobic crosslinked structures within the cell wall. The S. commune thn mutation is analogous to the Stveptomyces bid mutation. In A. nidulans , disruption of the analogous vodA gene encoding a hydrophobin- like protein resulted in a decreased hydrophobicity of aerial mycelium (Stringer et al., 1991. for review see Chater, 1991). In addition to the formation of aerial hyphae, hydrophobin genes are also involved in fruitbody formation in S. commune (Wessels et al., 1991b). The possible reduced levels or even absence of these or other similar crosslinked structures in the cell walls of "Abade' might contribute to better digestibility of the cell walls by lytic enzymes resulting in higher yields of protoplasts observed by us. It is difficult to imagine that the known adenine-auxotrophic mutation in 'Abade' would have such a dramatic effect on cell wall synthesis. Therefore, we assume that other defects may be present in 'Abade' . However, we cannot rule out the possibility that some key functions would be defective resulting in pleiotropic effects on both adenine-requirement and cell wall assembly. It may be significant to note that the ade mutation in 'Abade' does not result in absolute adenine-auxotrophy. After transfer of mycelial inocula on media without adenine and longterm incubation, we have observed some slow growth, perhaps feeding on the inner parts of the colony. This phenomenon of slow growth has been associated by others with instability of the ade mutation.
In addition, the known adenine-requirement of 'Abade' cannot solely explain its better transformability. Strain UlmplO was isolated (with other similar "colonies) after protoplasting and regeneration on CMPS-medium of strain Ul, which was also purchased from the ATCC-collection (ATCC62462) . In addition to a number of normal appearing regenerates, the UlmplO-type of colonies were isolated because of their resemblance with the 'Abade'-phenotype. The
frequency of their generation was about 0.08. This phenotype was still retained after the regeneration plate was fully covered with outgrown regenerates. At the moment of the isolation of inocula for further propagation, the colonies touched neighbouring colonies (mp stands for mating protoclones) . In addition to the flatter type of growth the UlmplO-type of colony also revealed densely packed hyphae, especially in the middle of the colonies. Another form of altered morphology was apparent i.e. the marked reduction of the presence of hyphal aggregates as is visible by absence of a thread-like morphology. After further propagation it appeared that the aberrant morphology was transiently retained on CMP and MMP agar medium, with a later tendency to form aerial hyphae. For the production of cultures on MMP + cellophane and subsequent cultivation in liquid medium the outer differentiating parts of the colonies were avoided. From the later experiments, including α-exterase isozyme-analysis and fruitbody induction from UlmplO-derived transformants, it was concluded that the UlmplO-type of colony was not a homokaryon, but a special type of heterokaryon. The primary UlmplO- transformants either had the Ul phenotype (50%) or the UlmplO phenotype (50 ) . After prolonged cultivation all primary transformants formed sectors with the Ul phenotype.
It is well-known that protoclones derived from a heterokaryotic parental strain may demonstrate a tremendous variation in morphologies. In plant biotechnology this phenomenon is denoted somaclonal variation. These findings are best explained with the assumption that imbalances have occurred during protoplast formation and/or regeneration with respect to the presence of cellular organelles and/or nuclei. These phenomena may well represent a stress to the organism which is accompanied by the development of competence for transformation. Numerous examples exist of improving transformation efficiencies by pretreatment of the host or the donor DNA with (UV)-radiation or carcinogens. This was in fact the reason why we attempted the use of linear DNA's which provides numerous double- strand breaks. It is well-known from other systems that these double- strand breaks may induce repair mechanisms and recombination machineries. It is anticipated that in "Abade' , which only yields one type of regenerates, this stress may be constantly present if not only the ade mutation is present, but also other undefined mutations. The efficiency of protoplast formation cannot be the only reason for transformability of A. bispo-vus , because from UlmplO successful transformation experiments were conducted with 2.7 x 106 protoplasts.
Therefore, we assume that some elements involved in the morphological aberrations, possibly by the action of pleiotropic effects, may improve the competence for genetic transformation, e.g. by the induction of S.O.S.-systems. In a further preferred embodiment of the invention the donor DNA is linearized prior to transformation as this leads to a more positive effect on the transformation efficiency. This positive effect of the use of DNA that is linearized prior to transformation on transformation efficiency is in line with observations in other organisms than homo- basidiomycetes such as the yeast Hansenula pol movpha (Faber et al. 1992) and some filamentous fungi (Banks et al. 1992, Liou et al. 1992, Tsai et al. 1992).
Any commonly acceptable method for transformation of protoplasts can be used in the method according to the invention, such as electropora- tion, use of PEG or particle bombardment. A person skilled in the art will be able to determine which method best suits the homobasidiomycete material to be transformed, whether it has been derived by protoplasting or not. The use of electroporation to mediate uptake of donor DNA is a good choice due to the cell type specific controllability of parameters. Furthermore the use of electroporation eliminates the risk of aggregate formation of protoplasts by PEG and thus prevents potential segregational instability of the donor DNA. This effect may be even more realistic for multinucleate A. bispovus.
In another preferred embodiment of the method according to the invention the efficiency of transformation can be significantly increased by taking measures to ensure a higher yield in the number of protoplasts per unit time prior to the actual transformation step. Methods are known to a person skilled in the art for increasing protoplast yield and regeneration efficiency (Sonnenberg et al 1988) . It is -pointed out here that the known methods for increasing protoplast formation as such are insufficient to obtain transformability of the host homobasidiomycete material. This was illustrated by the non transformability of Ul. As however the chances of finding transformants are increased by such measures the inclusion of such measures in the method according to the invention is preferred.
As disclosed the rejuvenation is an important aspect of the subject method. Rejuvenation as such is a known procedure (Fritsche 1991) and can occur in the form of natural rejuvenation or artificial rejuvenation. Natural rejuvenation occurs in the form of mating homokaryotic spore
cultures leading to mating products which are considered to b rejuvenated offspring. In the method according to the invention furthe homokaryotes can be derived from the rejuvenated offspring fo transformation. The artificial method of rejuvenation comprises formatio of protoplasts, regeneration and selection of homokaryons therefrom.
In particular the invention is thus directed at a method fo obtaining a dominant selectable stable transformant of homobasidiomycete capable of expressing stably integrated donor DN comprising at least a dominant selectable marker at a detectable level, said method comprising a) subjecting the mycelium of the host to be transformed to at least:
1) protoplast formation, followed by
2) an outgrowth phase to colonies, followed by
3) isolation of individual protoclones resulting from step 2, followed by
4) an outgrowth phase to colonies followed by
5) a selection of a protoclone resulting from step 4 on the basi of exhibiting a delayed differentiation in comparison either t non-protocloned homobasidiomycete material and/or the wild typ strain Ul as obtainable from ATCC, said delayed differentiatio being macroscopically visible in the form of amended morpholog due to a change in the number and/or height of aerial hyphae, preferably by the absence of aerial hyphae and/or by diminished hyphae aggregate formation preferably by the absenc of hyphae aggregates.
6) optionally at least one cycle of further propagation of selected clone, including a subsequent outgrowth phase t colonies and cultivation, preferably in liquid medium
7) at least one protoplast formation step from such a colony and subsequently b) subjecting protoplasts resulting from step 7 to transformation wit donor DNA. With the method according to the invention the host to b transformed can optionally be non-auxotrophic and can also b transformed with said dominant selectable marker withou cotransformation.
The indicated pretreatment of protocloning the host material to b transformed prior to the actual transformation step appears to improv the success rate of transformations. Parallel transformation experiment
in which Ul and UlmplO were compared yielded only transformants from UlmplO, but not from Ul indicating the preferred use of protocloning.
In a more preferred embodiment of this method according to the invention the material to be used in step b) for transformation has not been subjected to more than 5 successive outgrowth phases in step 6. The use of recently protocloning material for the transformation apparently enhances the success rate of obtaining transformants from a commercial strain, which was previously not transformable.
In a further preferred embodiment of the subject method of protocloning and transformation of such protoplasts with donor DNA comprising a dominant selectable marker the protoplast formation step can be further improved by growth of fungal mycelium in plant medium for cultivation and regeneration of plant cells e.g. MS medium (Murashige and Skoog 1962) immediately preceding step 7• This additional measure has been found to be particularly effective for a host belonging to the genus Agavicus. It seems that the application of MS-medium during cultivation in liquid medium causes a less densely packed type of mycelium and perhaps also prevents the deposition of extracellular or cell wall specific metabolites that might interfere with the activity of the lytic enzyme used for protoplasting. On the other hand MS-medium lacks some essential components (which are present in DTδO) needed for long term cultivation of Agavicus . The shift from a rich medium to a poorer medium for the induction of competence for genetic transformation is also well known for other transformation systems e.g. Bacillus s bti lis and E. coli . For the transformation methods according to the invention in the various embodiments described above the transformation can be successfully carried out using donor DNA comprising at least a dominant selectable marker. The selectable marker can for example encode resis¬ tance to an antibiotic and/or a fungicide. The resistance encoding sequence can suitably encode for resistance against hygromycin B. Such resistance can be provided by the hpt gene. The gene sequence is known for hpt from both E. coli and Stveptomyces . The sequence from E. coli is used in the Examples and is eminently suitable for use in a method according to the invention. The donor DNA can further comprise at least one nucleotide sequence homologous to a part of the DNA of the non-transformed host. The presence of such a homologous sequence can imply the presence of a sequence at which integration is desirable in the host chromosome, i.e. in order for site specific homologous recombination to occur. It can also imply the
presence of homologous control sequences in order to ensure optimal processing of the donor DNA by the host. Preferably the donor DNA further comprises a promoter and optionally a terminator sequence homologous to the host to be transformed. In general no critical demands other than the usual ones on shuttle vector composition generally applicable and well known to a person skilled in the art of transformation of other organisms, in particular basidiomycetes beside the already mentioned presence of the dominant selectable marker are made on the vector to be used. It has however been found that a specific new vector can quite successfully be used for transformation purposes of the hpt gene as dominant selectable marker. The vector is obtainable by at least the following essential steps:
1) Introduction of an -Vcol-site comprising the methionine-encoding translation initiation codon of the hpt gene e.g. via the PCR method using the wild-type E. coli hpt-gene or plasmids pHRC or pAN7-l as templates and combinations of the following primers having seq. id 1, 2 as illustrated in the sequence listing.
2) Removal of the unique Ncol- and EcoRI-sites from the wild-type hpt coding region by in vitro mutagenesis e.g. via PCR using primers having sequence id 3 and 4.
3) Cloning of the fragment altered in steps 1 and 2 in a proper E. coli (e.g. pUC-based) vector.
4) Introduction of EcoRI/NcoI genomic fragments preferably from A. bispovus and optionally comprising promoter activity.
5) Introduction of SαmHI-Hindlll genomic fragments preferably from A. bispovus and optionally comprising terminator" activity.
6) Propagation of this plasmid DNA in a proper host strain preferably lacking or mutated for the capacity to restrict and/or modify cloned homobasidiomycete DNA.
The invention covers this vector and also use thereof in any of the transformation methods according to the invention. In particular a vector according to the invention comprises a promoter controlling the dominant selectable marker of the donor DNA, said promotor being derived from the host to be transformed. For transformation of A. bispovus a vector comprising an A. bispovus promoter is for example preferred. Suitably a pAN7-l vector can be modified when e.g. an A. bispovus promoter replaces the A. nidulans promoter. Preferably a strong promoter sequence will be used to control expression of the dominant selectable marker in a vector
according to the invention. The strength of the promoter can generally be derived from the level of expression of a gene so that any promoter of a gene encoding a product that is present in large amounts will be suitable. An eminently suitable promoter for transformation vectors for A. bispovus is the GPD-2 promoter sequence. A pAN7~l modified vector comprising the A. bispovus GPD-2 promoter sequence instead of the A. nidulans promoter sequence controlling expression of the hpt-gene is comprised within the invention.
Also termination sequences that can be recognised both by A. nidulans and A. bispovus are preferably absent in a vector according to the invention. In the case of the pAN7~l vector being modified for use in A. bispovus as a vector according to the invention the termination sequences such as present in the TRPC terminator sequence of A. nidulans are preferably removed. A further improvement of a vector according to the invention, in particular a pAN7~l modified vector comprises the presence of a mutated E. coli hpt gene as gene encoding the dominant selectable marker. The mutated E. coli hpt gene comprises a CG duplet at position 799 from the 5'-iVcoI-site comprising the ATG start codon instead of the native GC duplet. Consequently the mutant hpt-gene encodes Ile-Val instead of Met- Leu. The mutated sequence driven by proper expression signal sequences resulted in a higher resistance level of E. coli transformants. A vector comprising any other mutation in a hpt gene resulting in a higher resistance level of host transformants is included in the scope of the invention.
For homologous integration it is desirable to include a sequence of nucleic acid homologous to a part of the chromosome of the host to be transformed. A suitable sequence for A. bispovus comprises the AbGH3 sequence, a sequence that can be isolated through hybridisation with putative N cvassa tyrosinase sequences obtained by PCR with degenerate primers and published sequences (Lerch 1992) in a manner known to a person skilled in the art. Any number of alternatives will be apparent to a person with knowledge of homologous integration and with access to the known DNA sequences of the host to be transformed. A preferred vector according to the invention for transforming A. bispovus will comprise the homologous strong promoter GPD-2 controlling the dominant selectable marker, the E. coli hpt-gene with the mutated duplet disclosed above and will also comprise a sequence of homologous
nucleic acid for A. bispovus such as AbGH3 if homologous integration is desired.
It is possible to also carry out cotransformation" with the trans¬ formation method in the various embodiments of the invention disclosed. Besides the transformation with the donor DNA comprising the dominant selectable marker as primary marker as described it is possible to introduce by co-transformation further DNA comprising a desirable sequence to additionally transform the host. The technique of co- transformation allows the introduction and stable integration of any DNA sequence together with the primary (e.g. hpt) selectable marker. In order to increase co-transformation efficiencies, in particular in A. bispovus which exhibits low (±10%) cotransformation efficiencies, transformation vectors can be constructed comprising both the primary selectable marker and the cotransforming sequence (figure 19). The resulting transformants comprising the cotransformed DNA can be demonstrated by Southern blot analysis. The cotransforming DNA may code for any homologous or hetero¬ logous polypeptide or protein which may or may not be excreted, thus affecting metabolic and biochemical potential of the transformant when expressed in the proper tissue and at the proper growth stage. Specific homologous or heterologous genes may also be over-expressed by using a strong (e.g. GPD-2) promoter or by insertion of higher copynumbers of the same gene. GPD which is a constitutive enzyme, may constitute about 5% of total cellular protein. The addition of rDNA sequences might also favour the integration of multiple copies. Alternatively, a specific gene may be repressed by different techniques. In the yeast Sacchavomyces cevevisiae and some fungi, like A. nidulans and Neuvospova cvassa, where homologous integration may occur relatively frequently, gene-disruption may be the best technique to silence a specific gene (Fincham 1989) - The probability of the occurrence of homologous (site-specific) integration has been correlated with the length of the homologous insert of the donor DNA plasmid with linearization of the donor DNA plasmid within the homologous insert sequence. We have applied this system by cloning the AbGH3~ Sin lll-fragment into the unique Hindlll site of pAN7-l generating pHAG3~ 1, followed by digestion of the unique Kpnl-site within the AbGH3- sequence. Phenomena like antisense RNA inhibition and co-suppression are common in plant genetic engineering, but may not be applicable in heterokaryotic fungal transformants containing only one (co)transformed nucleus, unless both nuclei have been transformed directly or combined by mating or protoplast fusion. Co-transformation with sequences coding for
specific antibodies (in plants denoted 'plantibodies' Hiatt 1990), however, may find general applicability. It appeared that also parts of antibodies comprising the variant (Fv) chains and expressed in E. coli may have sufficient binding capacities (Plϋckthun 1990) , possibly also for application in fungi (fungibodies) .
Desirable sequences for example suitable for cotransformation using the transformation procedure according to the invention are the putative A. bispovus tyrosinase genes (isolated at our institute) cloned sense or antisense, the A. bispovus mannitol-dehydrogenase gene or the glucose-6- phosphate dehydrogenase gene (Wood et al. 1991). the A. bispovus methallo- thionein genes (Nishiyama et al. 1990), e.g. the barley α-thionin gene (Gausing 1987) or resistance to dsRNA viruses through cross-protection using a gene coding for e.g. a coat protein (Harmsen et al. 1989. Harmsen et al. 1991)- In particular these sequences can be introduced into A. bispovus protoplasts by cotransformation according to the invention. It is in fact possible to insert multiple nucleic acid sequences from the cotransforming vectors at the same site in the chromosome. This is probably due to in vivo ligation of nucleic acid from the various vectors after linearization of the vectors has occurred such that compatible sticky ends or blunt ends are created prior to the integration event. Compatible sticky ends can be created simply e.g. by digestion of the vectors with the same restriction enzyme(s). It is also possible to insert sequences in tandem using one vector.
With the above mentioned methods for transformation that have now become available it is possible to produce stable transgenic fruitbodies directly from transgenic heterokaryons, like UlmplO primary transformants, or by matings or protoplast fusions between two compatible strains wherein at least one of the mating strains is a transformant obtainable from such a transformation method according to the invention. For example a suitable transformant to be used for such a method is an 'Abade* transformant comprising resistance to hygromycin B as transgenic selectable marker and comprising an adenine deficiency as does the non- transformed strain 'Abade' . This transformant can advantageously be mated with another mating strain that is not deficient for adenine and is also sensitive to hygromycin B, resulting in selectability of the product of said mating on both lack of adenine deficiency and resistance to hygromycin B. Such mating can take place by generally -known techniques such as naturally occurring anastomosis or artificial protoplast fusion.
It is also possible to produce homokaryotic material from trans¬ formed heterokaryotic material obtainable through the transformation method according to the invention. These homokaryons can be used for matings. As already indicated a method of providing a genetic fingerprint specific for a transformed homobasidiomycete comprising DNA analysis of a transformant or a transgenic fruitbody obtainable through a transformation method according to the invention also falls within the scope of the invention. In particular such a method is described, wherein a genetic fingerprint specific for heterokaryotic material resulting from a method of mating using a transformant obtainable through the transformation method according to the invention as at least one of the mating strains, can be determined distinguishing said heterokaryotic material from the homokaryotic transformant used as mating strain by analysing for the presence of more or different genetic material in the heterokaryotic material than in the homokaryotic transformant. This can be carried out for example by counting the number of nuclei per cell or using protoplasts analysed in a cell sorter on the basis of the presence of about twice the amount of genetic material in the heterokaryotic mating product than in the homokaryotic transformant. Even more elegantly, use can be made e.g. of 'Abade' transformant C25-1 which contains the donor DNA integrated at the homologous AbGH3~sequence. Mating products with this strain as one of the two mating partners contain the native 3>5 kb AbGH Clαl-fragment and the C25-l/C_--αI fragment which has a much higher molecular weight (depending on the number of plasmid copies integrated) . When the second mating strain comprises different genetic material than the transformant mating strain the genetic fingerprint can be further completed with an "analysis of the RFLP, RAPD or isozyme band pattern of the resulting heterokaryotic material and comparison thereof to the starting material or any other known strains can be used to ascertain proprietary rights.
The invention is also directed at non-auxotrophic transgenic homo¬ basidiomycete material derived from a non-auxotrophic homobasidiomycete, said transgenic material comprising stably integrated donor DNA compris¬ ing a dominant selectable marker such as a resistance to antibiotic and said transgenic material further being capable of expressing said donor DNA in an amount sufficient to ensure selectability over the correspond¬ ing non transgenic material.
Certain aspects of the invention just described are further eluci¬ dated in the following detailed disclosure of the invention.
DETAILED DISCLOSURE OF THE INVENTION
GENERAL METHODS 1- Source and growth of mvcelia Strains from A. bispovus were purchased from the American Type Culture Collection (ATCC 24663, denoted 'Abade', and ATCC 62462, commercial strain Ul), inoculated on MMP agar medium containing Malt Extract (1%, Oxoid) , Mycological Peptone (0.5%, Oxoid) and agar (1.5%) and propagated at 24°C for 1-2 weeks for 3 generations each. Thus, the availability of inoculation material of identical generations was guaranteed for all individual experiments. Except mycelia needed directly for further processing, stocks were kept at 8°C. In order to prepare liquid cultures for the production of protoplasts, MMP plates containing a cellophane sheet were loaded with 5~10 inocula each and grown for ~10 days at 24°C. Colonies were subsequently scraped off the cellophane and macerated for 20 seconds in a Waring Blender, containing 50 mL of MSG20 (Murashige and Skoog 1962, containing 20 g.L"1 glucose) medium. For 'Abade' 20 μg.mL"1 adenine was added. The amount of macerated mycelium that corresponded with the material derived from two plates was inoculated in each Fernbach flask containing a final volume of 150 mL. Depending on the strain used growth was allowed while standing for 3~7 days at 24°C. Protoplasts were usually isolated from the mycelium grown in 3_4 Fernbach flasks.
2- Preparation and regeneration of protoplasts
The Fernbach cultures were rinsed thoroughly over cheese-cloth with sterile milliQ water and finally with 0.6 M sucrose. The mycelium was then transferred to an Erlenmeyer flask containing 0.6 M sucrose and 10 mg.mL"1 Novozym 234 (Sigma or Interspex Products Inc.) and incubated for 2-3 hours at 24°C. The formation of protoplasts was monitored micro¬ scopically with regular intervals. Their number amounted usually 108-109 protoplasts per experiment for 'Abade' and 106-107 for strains Ul and UlmplO. Protoplasts were purified by sequential filtration through cheese-cloth and 50 mL-syringes containing about 2 g of glass-wool, previously rinsed extensively with 0.6 M sucrose and pelleted for 30 min at 3000 rpm at 8°C using a Heraeus Christ centrifuge accommodating 4-6 100 mL tubes. Pellets were further purified by 2 washes with 0.6 M sucrose and 1 wash with SEH-electroporation buffer containing 0.6 M sucrose, 1 mM EDTA, 1 mM HEPES, pH 7.0, each time by centrifugation in 35
mL Corex tubes for min at 3500 rpm at 4°C using a Beckman RC-5C centrifuge and the HB4 swinging bucket rotor. Protoplasts were finally resuspended in 100 μL ice-cold SEH-buffer per parallel (usually 3-4) experiment. Alternatively, protoplasts can also be produced by growing colonies on membranes (e.g. Gene Screen, Dupont de Nemours and Co. Inc. NEN Products) layered on top of agar media containing a cellophane membrane. After growth, the membrane is incubated upside-down in the protoplasting solution for 1-2 h at 2 °C. Protoplasts can be recovered from the liquid phase and washed as described above. Regeneration of protoplasts was accomplished in two ways: 1- by plating directly onto CMPS agar medium (for the isolation of protoclones) or 2- by incubating in liquid CMPS for 3-5 days (for transformation experiments, see 4- transformation procedure) .
3- Cloning procedures, preparation of plasmid DNA and Southern blot analysis of transformants
Cloning procedures were carried out essentially according to Maniatis et al. (1982). Transforming plasmid DNA was isolated using CsCl density gradient centrifugation or according to the Qiagen maxiprep extraction protocol. Transforming plasmids were pAN7~l (Punt et al. 1987) and pHAG3~l (a derivative of pAN7~l containing a 3 kb random A. bispovus genomic Hϊndlll-fragment (which weakly hybridised to a N. cvassa laccase specific oligonucleotide [Lerch 1982] cloned in the unique Hindlll restriction site of pAN7-l). Plasmid pAN7~l was linearized with Hϊndlll, pHAG3-l with Kpnl, which is located in the A. bispovus insert sequence, thus yielding two A. bispovus DNA termini. Restriction enzymes were used according to the suppliers recommendations (Pharmacia) . The DNA was then dialyzed for 30 min on Millipore VM membranes floating in a solution containing 10% glycerol and ImM EDTA or the DNA was phenol/chloroform- purified.
For the identification of transformants Southern blot analysis was performed on genomic DNA isolated essentially according to Raeder and Broda (1985), and comprising restriction enzyme digestions using condi¬ tions recommended by the supplier (Pharmacia, with 10-fold excess of restriction enzymes), electrophoresis, blotting and digoxigenin- dUTP/AMPPD (DIG) autoluminescence detection (Boehringer Mannheim) .
A new set of multipurpose fungal transformation vectors has also been constructed, which allow the convenient exchange of EcoRI-ZVcoI promoter fragments, the exchange of NcoI-BamHI structural gene fragments
and/or the exchange of BαmHI-Hϊπdlll terminator sequences. The construc¬ tion of these novel vectors is described in Example 2.
4- Transformation procedure Isolated protoplasts were resuspended in ice-cold SEH-electro- poration buffer and immediately electroporated with about 10 μg of donor DNA using the BioRad Gene Pulser (parameters, electrode gap: 0.2 cm; voltage: 0.45 k ; capacity: 25μF; shunt resistance: 200 Ω) , mixed immediately with 10 mL of CMPS medium (Compost extract 25% v/v, Myco- logical peptone 0.5% w/v, plus sucrose, 0.6 M) containing 100 μg.mL"1 cefotaxim (Duchefa) and incubated for 3_5 days at 24°C to regenerate cell walls. Then the suspension of regenerates was warmed briefly at 38°C and mixed with 1 volume of 2% SeaPlaque low melting point agarose plus sucrose 0.6M (38°C) and poured as overlays (5 mL per plate) on DT80 (Dijkstra Tween 80) medium (Dijkstra 1976, Sonnenberg et al. 1988) con¬ taining 10, 25 or 50 μg.mL"1 hygromycin B (Duchefa) plus adenine (20 μg.mL"1) for 'Abade' , or on DT8θ or B (plus glucose, 2%) medium containing 0 or 100 μg.ml"1 hygromycin B for UlmplO. Viability was tested before and after pulse delivery with serial dilutions on CMPS agar medium. Plates were incubated at 24°C. Regenerates became visible by microscopy after about 3 days. Transformants arose macroscopically after 1 to several weeks.
5- Cotransformation As an example of a method of cotransformation according to the invention co-transformation with pUT720, comprising the phleomycin (ble) - resistance gene from Stveptoa I loteichus hindustanus is described here. In addition, experiments with the Photinus pyvalis (firefly) luciferase gene as reporter system were carried out. Cotransformations were performed after linearizing both plasmids (e.g. pAN7-l and pUT720 by digestion with Hindlll) after mixing equal amounts of DNA containing the primary selectable marker and the cotransforming DNA (10-25 ug) . Hereby, the native and/or modified ble and/or mutated LUC genes (see below) were used as reporter genes for the determination of expression levels after integration into the recipient genome.
The hpt gene constructs described in example 2 have been used for promoter probing and promoter trapping (promoter fishing) experiments in a manner known per se to find promoters that are activated at specific
growth stages or under specific conditions. For this purpose A. nidulans promoter sequences were removed by digestion followed by electrophoresis and isolation of the proper vector-containing band from the gel by the Qiaex extraction protocol. For promotor-probing experiments random genomic A. bispovus fragments were ligated into the promoterless vector for transformation of E. coli . From all E. coli transformants obtained the plasmid DNA (now containing a variety of genomic A. bispo-pus fragments) was re-extracted and used for A. bispovus transformation as linear molecules. In case LUC or ble genes were used as reporter genes, the constructs were introduced with the hpt gene as primary selectable marker, by co-transformation. The promoter sequences may be recovered by techniques like marker or plasmid rescue, inverse PCR or PCR with one specific anchor-primer annealing to the donor DNA plus a random (RAPD) primer. For plasmid or marker rescue the genomic DNA of transformants is digested with a restriction enzyme, which does not cut the donor DNA introduced. Several restriction enzymes may be applicable separately. The total genomic DNA is then ligated to make the donor DNA plus the flanking genomic sequences circular, which can then be used to transform appropriate E. coli strains. The E. coli strain may be propagated to isolate the new recombinant plasmid for further analysis, including retransformation of A. bispovus . In case of tandem integrations the PCR- mediated techniques may be more suitable.
6- Marking of transformants Southern blot analysis of 'Abade' and UlmplO transformants obtained according to the invention revealed specific banding patterns upon restriction of the total DNA with Bglll , BαmHI or -EcoRI (or their combi¬ nation) , which cut the original vectors and upon hybridization with the hpt-probe. For each transformant analyzed the unique position of either single or multiple integrations was determined by the flanking genomic Bglll , BαmHI or EcoRI restriction sites. Thus for any transformant the number of hybridizing fragments generated and their specific sizes after single or multiple digestions is unique and may therefore be regarded as a transformant-specific and thus strain-specific fingerprint. In addi- tion, the unique flanking DNA sequences for each individual transformant can be determined following inverse PCR and sequencing.
7- Stability of transformants
The mitotic stability of 'Abade' transformants was assessed in two ways. Primary hygromycin B resistant colonies were grown on non-selective MMP agar medium covered with a sheet of cellophane for several (10) 'generations' , each time by transferring inocula from the edge of the colony. Phenotypic expression of the hpt-gene was checked for growth on DT8θ medium containing 10 or 25 μg.mL"1 hygromycin B and 20 μg.mL"1 adenine. The non-transformed strain and a colony that grew on a selective plate without having received any donor DNA (false positive) were taken as controls. It may be significant to note that with the experimental protocols now developed no or hardly any false positive colonies appear. UlmplO transformants demonstrated a sectored type of growth resembling the parental Ul strain. Sectors were investigated separately for retention of the hpt-gene and the hygromycin B resistant phenotype in the same way as for the 'Abade' transformants. The stability of transformants was also investigated by Southern blot analysis after growth of selected colonies on MMP agar medium. The position of autoluminescent signals detected after hybridization with the hpt-probe were compared with the positions of ethidium bromide-fluores¬ cent bands from the corresponding gel. This procedure shows whether the donor DNA has been integrated into the recipient genome or is present within the cells as free plasmids. By selecting proper restriction enzymes conclusions can also be drawn with respect to the integrated nature of the donor DNA.
8- Production of homokaryotic transformants from heterokaryotic primary transformants
Primary UlmplO hygromycin B resistant transformants were inoculated with up to five inocula per plate on GeneScreen (Dupont de Nemours and Co. Inc, NEN Products) hybridization membranes layered onto MMP agar medium and grown at 24°C for about 7 days. Membranes containing the colonies were then transferred upside down to petridishes containing 10 mL of 0.6 M sucrose containing Novozyme 234 (10 mg.mL"1). After incubation for 2-3 hours at 24°C protoplasts produced were recovered from the proto¬ plasting solution by centrifugation for 10 min at 3500 rpm and washed three times with 0.6 M sucrose by repeated centrifugations. Protoplasts were incubated for 3 days at 24°C in petridishes containing 10 mL of liquid CMPS medium to regenerate cell walls. Serial dilutions were then plated onto DTδO agar medium containing 10, 2 or 50 μg.mL"1 hygromycin B. Similar procedures have been described earlier for the production of
homokaryotic breeding material from heterokaryotic parental strains.
Homokaryons were generated with an efficiency of approximately 10%
(Sonnenberg et al. 1988). The nuclear constitutions were assessed e.g. using α-esterase isozyme analysis (Sonnenberg et al. 1988) and/or RAPD- mapping (Khush et al. 1991)-
9- Mating of transformants
For the production of transgenic fruitbodies from A. bispovus , a heterokaryotic constitution of the mycelium is required, which should contain at least two compatible nuclei with opposite mating types. Unless the initial transformant is already heterokaryotic (e.g. from UlmplO), heterokaryosis between homokaryotic strains or even between a homokaryotic and a heterokaryotic strain (socalled Buller phenomenon, Raper et al. 1972) may be accomplished by naturally occurring anastomosis, or artificially by protoplast fusions (see below).
For the initiation of anastomosis, inocula of about 2-5 mm2 were placed upside down onto non-selective MMP agar medium, about 1-5 mm apart. Inoculated plates were incubated at 24°C for 1-4 weeks. Within the zone where outgrowing colonies touch, compatible interactions may be observed resulting in pigmentation, in an aberrant mycelial morphology and the frequent excretion of intracellular material resulting in the formation of brown droplets in e.g. P. ostveatus (Kay and Vilgalys 1992). Similar phenomena were also observed for matings described here. Inocula from the interaction zones that also included some parental mycelium were transferred to new agar media for further analyses described below in example 5-
When a homokaryotic transformant, which is marked via the presence of a known Southern blot banding pattern produced after digestion of the genomic DNA with said or other restriction enzymes followed by Southern blot analysis with appropriate probes (described in section 'Marking of strains'), is mated with another preferably homokaryotic strain with a different RFLP-, RAPD- and/or isozyme banding pattern, the resulting heterokaryotic strain yields the same banding pattern as the original transformed 'Abade' homokaryon used as mating strain. This method is referred to as indirect marking of strains. The parental homokaryotic transformed strain can be distinguished from the new heterokaryon by additional counting of the number of nuclei per cell, by cell sorting of protoplasts or by RFLP-, RAPD-techniques and/or by isozyme analyses. An elegant example is given by using 'Abade' C25-1 as one of the mating
partners. In true heterokaryons the presence of two different AbGH3~ fragments can be demonstrated, due to the modified size of the AbGH3-ClaI fragment through homologous integration of pHAG3~l.
10- Stability of mated transformants
Heterokaryotic transformants that were generated by matings between 'Abade' hygromycin B resistant transformants and Ul protoclones, were transferred to non-selective MMP-medium covered with a sheet of cello¬ phane and propagated for several 'generations' , each time by taking one inoculum from the edge of a colony of about 5 cm in diameter to new MMP- plates plus cellophane, and another inoculum to test the ability to grow on double selective SD-medium containing hygromycin B (50 μg.mL"1) . After further propagation the remaining colony was removed from the cellophane and subjected to Southern blot analysis to verify the presence of the donor DNA.
11- Protoplast fusions with transformed protoplasts
Hygromycin B or phleomycin resistant transformants from A. bispovus can be used for the production of intra- or interspecies hybrids by protoplast fusions followed by dominant selection of fusion products.
Transformants, preferably (made) homokaryotic, derived e.g. from UlmplO and expressing the hpt or ble gene, may be fused to one another and fusion products may be dominantly selected by the simultaneous application of hygromycin B and phleomycin contained in the growth medium. They may also be fused to other organisms, containing another endogenous or donated dominant selection marker.
'Abade' transformants expressing the hpt or ble gene may be used for the dominant selection of fusion products with protoplasts expressing the complementing ADE gene, from any wild-type organism, but preferably from A. bispovus , A. bitovquis , A. avvensis or other Agavicus spp. Fusions of protoplasts have already been accomplished between A. bispovus and A. bitovquis (Patent number US4996390; 91-302364/41), between P. ostveatus and Lentinus edodes (Patent number JP4173034; 92-255378/31) and between a variety of different fungal species (Patent number J02245179. 90- 339235/45) • However, none of these fusions relied upon the presence and dominant selection of a donor DNA marker. Similarly, other fungal proto¬ plasts e.g. from P. ostveatus or L. edodes or even from plants e.g. Solanum tubevosum , which are sensitive to a hygromycin B concentration of about 50 μg.mL"1 or a phleomycin concentration of about 7-5 μg.mL"1 may be used
for the dominant selection of hybrids. In each case the transformed 'Abade' transformant donates the antibiotic resistance, whereas the fused counterpart donates the functional, complementing ADE gene.
Protoplasts from Agavicus spp (or e.g. P. ostveatus) were prepared as described above for 'Abade' and A. avvensis or according to Sonnenberg et al. (1988) and finally resuspended in 0.6 M sucrose. Then about equal amounts (100 μL, containing 107-108 protoplasts) of either protoplast type were mixed in a 15 mL pointed centrifuge tube (Corex) . One volume of 40% PEG6000 was added by pipetting carefully onto the centrifuge tube wall. By this way the PEG solution formed the lower layer at the interphase, covered by the protoplast suspension. Protoplasts were then centrifuged for 5 min at 800 rpm in a swinging bucket rotor using a table centrifuge (Beckman) onto the interphase, which allowed the formation of fusions. After standing for 5 min at room temperature 5 mL of 0..6 M sucrose were added and carefully mixed by inversion. Subsequently, the protoplast suspension was washed three times by centrifugation for 5 min at 2500 rpm in a table centrifuge and resuspended in CMPS for 3 days to regenerate cell walls and plated onto DTδO agar medium containing the proper anti¬ biotic. Serial dilutions were plated onto CMP agar medium to determine the efficiency of regeneration.
12- Production of transgenic fruitbodies
MMP agar plates covered with cellophane were inoculated with 5 inocula each of the desired transformed, mated or fused strain. Plates were incubated at 24°C for 10-15 days. Liquid cultures were prepared in Fernbach flasks containing 150 mL MSG20 (supplemented with 100 μg.mL"1 Cefotaxim) and the macerated material of 2 plates for each flask. The Fernbach flasks were incubated at 24°C for 3-5 days. Then for spawning 100 grams of wheat-grains were sterilized in the presence of 50 ml of demineralized water by autoclaving for 20 min. The sterilized wheat grains were added to the liquid Fernbach cultures and incubated at 24°C for about 2-3 weeks, dependent on the strain used. The total contents of overgrown wheat-grains plus remaining MSG20 medium were mixed with about 750 grams of pasteurized ready to use compost (CNC, Milsbeek, The Nether- lands) and incubated in a 5~10 L polystyrene box. The box was incubated closed, at 24°C for 2-3. weeks. Subsequently, a layer of casing soil of about 3 cm (CNC, Milsbeek, The Netherlands) was added on top of the compost now overgrown by the mycelium. The box was incubated closed at 24°C for another -8 days and then transferred to 16°C and a relative
humidity of 75-90%. The lid was then placed on 4 wooden pins in the corners of the box leaving a ventilation gap of 2-3 cm. The surface of the casing soil was moistened daily. After several days fruitbodies start to emerge. Fruitbodies can also be produced in jars essentially as described but with adapted amounts of mycelial inocula, grain kernels, compost and casing soil. Details are described in the legends to figure 17.
Example 1: Protoplasting and regeneration of 'Abade' and A. arvensis
Mycelia of 'Abade' and A. avvensis were grown in principle as described earlier (Sonnenberg et al. 1988) except for a growth phase in liquid MSG20-medium (Murashige and Skoog 1962, containing 20 g.L"1 of glucose as a carbohydrate source) instead of DTδO. With this medium we obtained extremely high yields of 'Abade' protoplasts of- over 5-7x 08 per 4 Fernbach flask cultures. Under similar conditions from P. ostveatus l.lxlO9 protoplasts were produced, suggesting the general applicability of this medium for the production of protoplasts from edible fungi.
Example 2: Construction of multipurpose transformation vectors
A novel convenient set of multipurpose transformation vectors has been constructed based on pUT720 purchased from Cayla, Toulouse, which contains pUC19 vector sequences, the Aspevgi llus nidulans GPDA promoter plus the Tvichodevma veesei cellobiohydrolase I (SSA ) excretion signal sequences, contained in a 2.2 kb EcoRI-iVcoI fragment, the Stveptoallo- teichus hindustanus phleomycin-resistance (ble) gene cloned as a 0.44 kb -VcoI-BαmHI fragment and the A. nidulans O.76 kb Bα HI-Hindlll TRPC-termi¬ nator fragment. After removal of the A. nidulans GPDA EcoRI-NcoI promoter fragment this vector can be used for the insertion of EcoRI-NcoI promoter fragments from any organism, but preferably from A. bispovus . Before or after exchange of the promoter fragments, the /VcoI-BαmHI ble gene frag¬ ment may be replaced by any structural gene, but preferably by the modi¬ fied E. coli 1.0 kb hpt NcoI-BamRI fragment or the Photinus pyvalis (fire¬ fly) 1.9 kb LUC (luciferase)-gene also contained in an adapted /VcoI-BαmHI fragment. The modifications are described below. The latter Ll/C-contain- ing construct may be used for transient expression assays, preferably in fungal protoplasts. Finally, the A. nidulans TRPC terminator sequence may be exchanged by any, but preferably A. bispovus terminator sequence, con¬ tained in a Bα HI-Hindlll fragment. The vectors thus constructed may be
used for the isolation and in vivo selection of random genomic sequences with promoter or terminator activity from any organism, but preferably from A. bispovus . This technique is called promoter or terminator fishing, respectively.
Modified hpt construct.
The E. coli hpt 1.0 kb BαmHI fragment (Gritz and Davies 1983). cloned into pAN7~l was used to introduce a ^ -Ncol site encompassing the ATG translational initiation codon by PCR overhang-extension. The hpt gene and 5'-adjoining sequences of plasmid pAN7-l, which is able to transform a number of different fungi (Punt et al. 1987) and which also was used for transformation of the basidiomycetes Schizophyllum commune (Mooibroek et al. 1990) and Pleuvotus ostveatus (Peng et al. 1992), was used as a template for PCR reactions. Figure 3 shows the schematic reconstruction of the hpt gene, containing a - -Ncol site, and with deleted Ncol and EcoRI-sites within the coding region. The PCR primers used for different steps in vector constructions are shown in table 1.
Primer Nco-HPT5 introduces an Ncol-s±te encompassing the translation initiation codon (ATG) of the hpt gene. Furthermore, introduction of this Ncol-s±te changes the second codon of the hpt gene in pAN7-l from proline to alanine. AnTRPC3C primes at the 3' end of the TRPC terminator of pAN7- 1. The PCR reaction yielded a 1.7 kb hpt-TRPC terminator fragment, which was isolated and digested with BαmHI, thereby separating the hpt gene from the TRPC terminator. Subsequently, partial digestion with Ncol was performed and a 1.0 kb fragment corresponding to the hpt gene was isolated and ligated into ZVeoI/BαmHI-digested vector pMTL23, yielding plasmid pMHN.
In order to remove the internal EcoRI- and Ncol-s±tes of the hpt gene in this construct (located at positions 244 and 352 relative to the ATG) , two phosphorylated primers were designed which mutate the EcoRI- and ZΫcoI-sites without changing the amino acid sequence (primers HPT-E2 and HPT-N2C, respectively). With these primers a 0.1 kb subfragment of the hpt gene was synthesized on template pAN7~l. Plasmid pMHN was digested with EcoRI, followed by partial digestion with Ncol at position 352, and treatment with Mungbean nuclease and CIP (calf-intestine alka¬ line phosphatase) to remove protruding ends and 5' phosphate groups. This vector was used to ligate the 0.1 kb PCR fragment, resulting in plasmid pMHMut carrying the hpt gene as a Ncol/BamΑl fragment in pMTL23- Sequencing of the new hpt gene revealed a change in the nucleotides at
position 799 from the ATG start codon (see below) . This change improved the resistance level of recombinant E. coli and the transformation efficiency of A. nigev. The hpt gene from pMHMut was cloned as an ZVcoI/BαmHI fragment into vectors with different promoters and the A. nidulans TRPC terminator (see below).
Table 1: PCR primers used for vector constructions
Code Sequence
NCQ-HPT5 Sequence id 1 ' GAC ATC ACC ATG GCT GAA CTC 3'
ATG. translation initiation site of hpt gene
AnTRPC C Sequence id 2
5' CCG CTC GAG TGG AGA TGT GGA 3' complement
HPT-E2 Sequence id 3
5' pAG TTC AGC GAG AGC CTG ACC 3' p, primer phosphorylated; A, position 244 relative to ATG of hpt gene
HPT-N2C Sequence id 4
5' pCAT AGC CTC CGC GAC CGG CT 3' complement; p, primer phosphorylated; C, position 36 relative to ATG of hpt gene
EN-LUC-1 Sequence id
5' GGG AAT TCC ATG CC ATG GAA GAC GCC AAA AAC ATA 3' ATG. translation initiation site of LUC gene
T7 Sequence id 6
5' TAA TAC GAC TCA CTA TAG GG 3' complement
AbGPDl Sequence id 7
5' G GAA TTC GTT GTC ATC ACC GCT CCT GGG AG 3' G, position -1074 relative to ATG of GPDAs2 gene
AbGPD3 Sequence id 8
5' GAA GAA GAA TTC AGA GGT CCG CAA GT 3'
G, position -290 relative to ATG of GPDkB-2 gene
AbGPD2c Sequence id 9 5' GCT TAT CGC CAT GGT TTG TCT CTC 3* complement; CAT, complement of ATG of GPPAg2 gene
PR-HPT1 Sequence id 10
5'-ATG.AAA.AAG.CCT.GAA.CTC.ACC.GCG.ACG.TCT-3' (encompassing ATG at position 1)
PR-HPT2c Sequence id 11
3'-GGG.TCG.TGA.GCA.GGC.TCC.CGT.TTC.CTT.ATC-5*
(complement, encompassing TAG around position 1050)
PR-LUC-1 Sequence id 12 '-ATG.GAA.GAC.GCC.AAA.AAC.ATA.AAG.AAA.GGC-3'
(encompassing ATG at position 304)
PR-LUC-2c Sequence id 13
3'-CAC.CGG.GGC.CGA.CTT.AAC.CTT.AGC.TAT.AAC-5* (complement, encompassing position I896)
Modified luciferase construct. In order to introduce an iVcoI-site encompassing the ATG of the LUC gene from P. pyvalis , primer EN-LUC-1 was designed. This primer was used together with the (standard) T7 primer and plasmid pT3T7~LUC (Promega) in a PCR reaction which yielded a 1.8 kb LUC fragment. After digestion with Ncol and BαmHI the LUC gene was ligated into vector pMTL23 digested with Ncol and BαmHI, which yielded plasmid pLUC-N. The LUC gene was cloned as an Ncol/BamRl fragment into vectors with different promoters and the A. nidulans TRPC terminator (see below). The integrity of the mutated hpt- and LUC-genes was assessed by positive expression in E. coli after cloning
in appropriate expression vectors. The modified hpt gene also resulted in a higher transformation efficiency in A. nigev.
Promoter constructs. In A. bispovus two GPD genes have been detected which are separated by a 0.29 kb intergenic region. Only the downstream GPDks2 gene is active in mycelium (Harmsen et al. 1991)* The promoter region of this gene is used in new transformation vectors because of its high level of expression and because it normalizes the generation of mRNA when fused to the hpt gene (see below) . Two different sized promoter fragments were isolated via PCR. A 0.29 kb fragment, representing the intergenic region of the two GPD genes, was isolated using primers AbGPD3 and AbGPD2c. Primers AbGPDl and AbGPD2c were employed to obtain a 1.0 kb fragment which extends into the coding region of the upstream GPDkgl gene. Both fragments have the -Vcol-site, encompassing the translation initiation site of the GDPks2 gene, as the 3' end. The two fragments were isolated by PCR on genomic DNA from both A. bispovus Ul and 'Abade' .
Primers AbGPDl and AbGPD3 introduced an -EcoRI-site at the 5' end of the PCR fragments. Thus, the fragments were cloned as EcoRl/Ncol frag- ments into EcoRI/iVeoI-digested pUT720, thereby replacing the A. nidulans GPD promoter by the A. bispovus GPD promoter fragments. This procedure yielded plasmids pFAAGl and pFUGl (containing 1.0 kb GPD promoter frag¬ ments from 'Abade' and Ul, respectively) and pFAAG2 and pFUG2 (containing 0.29 kb GPD promoter fragments from 'Abade' and Ul, respectively). These plasmids therefore, contain GPD promoter sequences fused to the S. hindu- stanus ble gene and the A. nidulans TRPC terminator.
These plasmids were digested with iVcoI and BαmHI to replace the ble gene by the LUC gene which was isolated after Ncol/Bamϋl digestion of plasmid pLUC-N (see 'Modified luciferase construct'). The resulting con- structs were named pAbAGLl and pAbUGLl (containing 1.0 kb GPD promoter fragments from 'Abade' and Ul, respectively) and pAbAGL2 and pAbUGL2 (containing 0.29 kb GPD promoter fragments from 'Abade' and Ul, respec¬ tively) .
Furthermore, the LUC gene was ligated directly into Ncol/BamRl- digested pUT720, creating construct pAnGLl, and into pUT720, in which the EcoRl/Ncol A. nidulans GPD promoter fragment including the signal sequence from the SSA cellobiohydrolase I gene from T. veesei was replaced by the EcoRl/Ncol A. nidulans GPD promoter fragment from pANδ-1, yielding pAnGL2.
Analogous to the construction of the LϋC-containing plasmids described above, constructs were made with the modified hpt gene from plasmid pMHMut. These constructs are: pAlH (analogous to pAbAGLl), pUlH (analogous to pAbUGLl) , pA2H (analogous to pAbAGL2) , pU2H (analogous to pAbUGL2) , pAnHl-5 (analogous to pAnGLl) and pAnH2~5 (analogous to pAnGL2) .
The methods described here may be applied for the construction of transformation vectors with any, but preferably A. bispovus promoter sequence and/or with any, but preferably A. bispovus transit signal sequence and/or with any homologous or heterologous structural gene or fusions thereof and/or with any, but preferably A. bispovus terminator sequence.
Example 3: Transformation of 'Abade' protoplasts through electroporation with linear plasmid DNA.
Figure 1 shows hybridization signals from linearized plasmids pAN7-l (6.5kb) and pHAG3~l (9>5kb), lanes 1 and 2, respectively, from genomic 'Abade' DNA, lane 3 and from the genomic DNA isolated from colonies all recovered from selective plates (DTδO plus hygromycin B and adenine) . Strains AlO-1 and A25-1 had not been exposed to any donor DNA, thus representing the well known false positives which were only detected during early transformation attempts. Strains BlO-1 and B25-2 had originally been exposed to native (non-digested) pAN7~l. Strain B25-2, lane 7. is apparently also a false positive, whereas B10-1 is a true transformant characterized by the hpt-specific hybridizing signal at the position of the non-digested chromosomal DNA, indicating that the donor DNA had been integrated into the 'Abade' genome. Integration was also observed after electroporation with linear pAN7~l (C25-I and C25-2, lanes 8 and 9, respectively) and with linear pHAG3-l (DlO-l, D10-2, D10-3 and D25-1, lanes 10, 11, 12 and 13, respectively). No free plasmid migrating at the approximate position of the linear plasmids has been observed at any occasion. These data also support the stable nature of the hygromycin B resistant transformants.
Figure 2 shows a Southern blot analysis of the genomic DNAs from four 'Abade' hygromycin B transformants after digestion with different restriction enzymes. In each transformant bands were detectable at the same position as the linearized pAN7~l or pHAG3~l plasmids, indicating that within the transformants tandem repeats had been formed during processing of the donor DNA. In addition, bands migrating at other
positions are detectable as well (except in lanes 5 and 6, from transfor¬ mant C25-2), indicating that double- or multiple integration events had occurred, which is quite common in fungal transformants. In addition, bordering fragments from the recipient also contribute to the generation of new bands. Figure 2 also shows that the individual transformants can be distinguished on the basis of their unique banding patterns, which may be considered a strain specific fingerprint.
The same procedure here described for transformations with the hpt gene was also successfully applied with the phleomycin resistance (ble) gene present in pUT720 and pAN8-l. These vectors contain the A. nidulans GPD promoter region, the S. hindustanus ble gene and the A. nidulans TRPC terminator region. Plasmid pUT720 also contains T. veesei cellobiohydro- lase I (SSA) excretion signal sequence (see example 2). The donor DNA was linearized via Hindlll digestion. After electroporation and regeneration (as described for the hpt gene) , regenerates were plated onto DTδO plates containing or 7-5 μg.mL"1 phleomycin (Cayla, Toulouse).
Example 4: Transformation of UlmplO, a derivative of commercial strain Ul. Protoplasts from strain UlmplO, which was isolated as described were transformed by electroporation with Hindlll linearized pAN7-l. The total number of protoplasts used for each individual experiment amounted 2.7xl06. A number of 2.3xl0/| regenerates was counted after plating serial dilutions and incubation at 24°C for about 7 days. From a DTδO plate containing 25 μg.mL"1 hygromycin B one transformant was obtained and from plant B5 medium (Duchefa, Netherlands) containing 50 or 100 μg.mL"1 hygromycin B in total 7 transformants were recovered within 3 weeks without any background growth. Figures 4 A, B and C show Southern blot analyses of all UlmplO transformants isolated in this experiment. The same insertional characteristics were observed as for 'Abade' transfor¬ mants described above, which is support for the stability of integrated donor DNA (figure 4A) .
The primary transformants had either the Ul-phenotype (50%) or the UlmplO-phenotype (50%) , immediately after isolation from the selective plate and further propagation on MMP. One major difference observed in UlmplO and 'Abade' hygromycin B resistant transformants was the consistent occurrence of differentiating sectors in those derived from UlmplO upon transfer to non-selective MMP-medium. In order to investigate the segregational stability of the donor DNA, inocula from individual
sectors were transferred to MMP-medium plus cellophane. Different sectors had a different growth rate. Between 1-4 weeks after inoculation the material was freeze-dried and subjected to Southern blot analysis. Figure 4B shows that with one exception in sector 3 from transformant UlmplO/BblOO-2 all sectors had retained the donor DNA. In the same transformant sector 1 and 2 had slightly different banding patterns. Figure 4C shows that transformant specific fingerprints were generated which allows discrimination between one another but also between 'Abade' transformants (figure 2).
Example 5 ' Production and dominant selection of A.bisporus heterokaryons containing an ade/hy and a wild-type nucleus
New strains were produced after mating homokaryotic hygromycin B- resistant transformants from 'Abade' and preferably homokaryotic protoclones from commercial strain Ul as described in the General procedures section 'Mating of transformants'. Figure 5 shows a representative result of experiments in which inocula from said interaction zones and both parental mycelia were grown on double selective SD-medium (Yeast Nitrogen Base without amino acids, prepared according to the suppliers instructions with glucose as a carbohydrate source, Difco Laboratories, USA) thus lacking adenin and supplemented with hygromycin B (50 μg.mL"1). Only inocula from said interaction zones exhibited growth contrary to either parental strain. When fresh matings were attempted between either parental strain directly onto said double selective agar medium, no growth was observed, indicating that the mating procedure described was essential to yield ADE/hyg-- colonies.
To rule out the possibility that double selected colonies were just mixtures of parental mycelia, protoplasts were produced, regenerated in liquid CMPS-medium and plated onto double selective SD-medium. The results demonstrate that with a high efficiency of about 90% again ADE/hyg-- colonies were formed. In about 10% of the regenerates no growth was observed by microscopy. These results confirm the heterokaryotic status of double selected crosses.
Example 6: Analysis of transformant DNA using PCR.
Total DNAs were extracted according to the protocol described earlier. Samples (100 ng) of template DNAs were subjected to PCR analysis with primers indicated in the legend to figure 6. PCR was performed using Tασ-polymerase in 30 cycles of 1 min 94°C, 1 min 55°C and 1 min 72°C. PCR-
products were electrophoresed in 1.0% agarose in TAE (Tris-HCl, acetate, EDTA)-buffer stained with ethidium-bromide.
Figure 6 shows clear banding patterns of specific PCR-fragments comprising parts of the tandem GPD1 and GPD2 genes of A. bispovus (lanes 2, 3. 4 and 5). indicating that both Abade and Ul have the same, or at least compatible, template DNA sequence of G-PD-genes, which is support for the proper classification of Abade as an A. bispovus "species, despite its aberrant colony morphology. From two putative (pAN7~l)-transformants in lanes 7 and 8, PCR-fragments with the same size were generated as in lane 9. which contained plasmid pAN7~l as a template, contrary to the non-transformed Abade control in lane 6. The results show that (stably or transiently) transformed Abade strains (C25-1 and DlO-1) can be obtained using the hpt-gene and procedures described and that the transformed status can be assessed using PCR and the primers listed above. Conclusions regarding the integrated nature of donor DNA sequences is shown by Southern blot analysis in a number of other examples.
Example T: Identification of transformed fruitbodies derived from UlmplO.
Fruitbodies were produced as described in the general methods. The Southern blot analysis shown in figure 7 clearly demonstrates the presence of donor DNA sequences in each fruitbody sample analyzed except for the primary transformant (UlmplO/BblOO-2) that had lost the donor DNA in one of the three sectors observed (figure 4B) . This result indicates that the donor DNA has been stably maintained throughout fruitbody development, despite the absence of any selective pressure in favour of the hpt-containing nuclei. There is no sign of differential segregation of any one of the transformed nuclei. In at least three transformants identical hybridization patterns were obtained in the starting mycelium and the derived fruitbodies. In cases of doubt, additional digestions with other restriction enzymes and/or the determination of adjacent genomic sequences may provide conclusive discrimination. It can be concluded that donor DNA sequences are transmitted to A. bispovus fruitbodies with high frequency and usually with hybridization patterns identical to the mycelial pattern. These patterns can suitably be used to assess proprietary rights.
Example 8: Southern blot of transformant DNA derived from 'Abade'.
Total DNA was isolated and Southern blot analysis was carried out as described in the general methods section.
All mating products shown in figure 8 contain the two bands which are also visible in the transformed Abade parents (DlO-1 and C25-1, lanes 1 and 2) and the pAN7~l control (lane 19). This indicates the presence of pAN7~l sequences in the genome of the mating products. As expected, the parental Ul protoclones do not contain any sequences hybridizing to the hpt-probe. The faint signal present in lane 12, panel C, is most likely due to overflow of DNA from the neighbouring slots. The hybridizing bands remain present for three generations in all mating products. However, additional bands appear in later generations. Whether these are caused by partial digestion or by rearrangements of the transforming DNA, or other donor DNA processing events, remains to be investigated. -It can therefore be concluded that the mating products between Abade transformants and Ul protoclones stably maintain pAN7-l sequences in the genome for at least three generations.
Example 9: Cotransformation with pAN7-l and pUT720.
Before transformation both plasmids pAN7~l and pUT720 were linearized with Hindlll. After electroporation of Abade protoplasts as described in the general methods section, transformants were selected on hygromycin-containing medium. DNA from the hygromycin-resistant colony D20-1 was isolated and subjected to Southern blot analysis as described in the general methods section.
The restriction enzymes used for Southern blot analysis shown in figure 9. all have only one recognition site in both pAN7-l and pUT720. Thus, the bands of approximately 6 kb in panel A corresponding to the size of plasmid pAN7~l indicate the presence of tandemly integrated copies of pAN7-l in the genome. Ncol and BαmHI digests (figure 9A, lanes 5 and 6) show additional fragments hybridizing to the hpt-probe, which probably represent border fragments containing neighbouring genomic DNA. Such border fragments were not observed when a Me-probe was used (figure 9B, lanes 5 and 6). This suggests that one or more copies of pUT720 have co-integrated with and are surrounded by pAN7-l sequences. The patterns suggest that all pAN7~l and pUT720 copies are arranged in the same orientation. Since the Hindlll digests also show plasmid-sized bands (figure 9A and 9B, lanes 7). the tandem copies were probably obtained by ligation of the linearized plasmids before integration into the genome. Figure 90 (hpt- and J Ze-probes) shows a combination of the patterns obtained in panels A and B. As pUT720 and pAN7~l have somewhat different sizes (6.04 and 6.55 kb, respectively) double bands appear around 6 kb.
The Hindlll-linearized pAN7~l and pUT720 plasmid molecules have co- integrated into the genome after ligation in vivo . Thus, co-integration is possible by linearizing both plasmids with the same restriction enzyme.
Example 10: Production of homokaryotic protoclones from primary heterokaryotic transformants.
Inocula from fertile, primary transformant UlmplO/BblOO-l which included tissues from all three sectors observed, were grown on GeneScreenPlus (DuPont) hybridization membranes layered on top of cellophane sheets in petri dishes containing MMP agar medium. The plates were incubated at 24°C for 2 weeks. Then the membranes accommodating the colonies were removed, washed in 0.6 M sucrose and incubated upside down in a petri dish containing 10 mL of 0.6 M sucrose plus Novozyme 234 (10 μg.mL"1) at 24°C for 1 hour to release protoplasts. Protoplasts were purified from the supernatant by sequential centrifugations with 0.6 ty. sucrose, resuspended in 5 mL of 0.6 M sucrose plus 1% Low Melting Point agarose (37°C) and plated onto CMPS (compost extract, Mycological Peptone, sucrose)-agar medium. Petri dishes were incubated at 24°C and individual colonies isolated, aided by microscopy, before touching their neighbours. Nineteen colonies were isolated with equal viability. From these colonies new inocula were tested for growth on DTδO-medium (not shown) or DTδO-medium containing 50 μg.mL"1 hygromycin. Non-transformed UlmplO was included as a control (colony A4) . The results in figure 10 show that different types of protoclones have been produced with different pigmenting (and different levels of pigments excreted into the medium surrounding the colonies, which is not visible on the photograph). Control A4 did not grow, nor did colony B3 (Ulmpl0/Bbl00-lpl4) , which shows that by the procedure of protoplasting and dilute regeneration protoclones may be isolated which lost the nucleus containing the integrated hpt-sequences. Thus, colony B3 exclusively contains the non-transformed nuclear type, which makes this strain a homokaryon. Support for protoclonal segregation instead of deleterious recombination events is provided by the frequency obtained (1 homokaryon out of 19 protoclones tested) . This frequency is expected if from heterokaryons as the starting material homokaryons of either nuclear type have been generated with an efficiency of 10%, which is the published efficiency. Further support was obtained by α-esterase isozyme- analysis (not shown) . With similar frequency homokaryotic protoclones
were also identified by α-esterase analysis that still contained the hpt- gene. These protoclones can be used as mating partners with other homokaryons to introduce the donor DNA into a new heterokaryon.
By the method of protoplasting and dilute regeneration of primary UlmplO (hpt) - transformants homokaryotic protoclones of two nuclear types can be isolated. One type, which lost the capability to grow on hygromycin-containing medium and the other type which still contained the hpt-gene.
Example 11: PCR-analysis of donor DNA selectable markers into protoplasts.
Protoplasts (3 x 107) were isolated and extensively washed in EB (electroporation buffer) as described in the general methods section. Then 30 μg of plasmid pAN7~l was added, the mixture of protoplasts plus DNA was divided into three portions (107 each) and incubated on ice. To the first portion (1) of 107 protoplasts plus pAN7~l (10 μg) , plasmid pT3T7-luc (10 μg) was added directly. Portions 2 and 3 were subjected to electroporation according to the parameters described in the general methods section, incubated at 30°C for 30 min to allow sealing of pores generated by the electroporation procedure, and then transferred back to ice. To these two portions plasmid pT3T7~luc (10 μg to each portion of protoplasts) was also added followed by extensive washing with 0.6 M sucrose containing MgCl2 (20 μg.mL"1) . Then DNAse I was added to portion 2 only (final concentration of 20 μg.mL"1). Portions 2 and 3 were incubated for 30 min at 30°C, then put back on ice and lysed with phenol/chloroform simultaneously with portion 1. Total DNA was then extracted according to the method described and subjected to PCR for 15 or 20 cycles using digoxigenin-11-dUTP in the dNTP nucleotide mixture and the sets of primers indicated in the legend to figure 11. After electrophoresis the PCR-products were blotted onto a nylon membrane, treated with antidigoxigenine-AB, Fab-fragment, and AMPPD solution, exposed to FUJI medical X-ray film and developed. Portions 1, 2 and 3 correspond to fig. 11, lanes 1, 2 and 3. respectively.
Using PCR and the primer sets indicated in the legend to figure 11 it is possible to determine the entry of donor DNA - into A. bispovus protoplasts by electroporation parameters described in the general methods section. Additional higher molecular weight bands only occurring in portions 2 and 3 possibly represent early processing of the donor DNA after entry.
Example 12: Northern blot of transformed fruiting body RNA
Ulmpl0/Bb50-1 fruitbodies were produced in jars essentially as described in the general methods section with adapted amounts of mycelial inocula, grain kernels, compost and casing soil. Details are described in the legends to figure 17- Fruitbodies were harvested at different timepoints. RNA was isolated from freeze-dried material and Northern blotting was carried out by standard procedures. The blot was hybridized to a 32P-labelled hpt-probe.
Figure 12 shows a Northern blot analysis of RNA extracted from transgenic fruitbodies. After isolation the RNA showed considerable degradation on an ethidium bromide-stained agarose gel. Therefore, the signals on the Northern blot are weak and vague. However, the hpt-gene clearly appears to be expressed in transgenic fruitbodies.
Example 13 Southern blot analysis of Abade transformants derived with pHAG3-l
Abade transformants were obtained with plasmid pHAG3~l,linearized with Kpnl within the A. bispovus AbGH3 insert sequence. DNA isolation and Southern blot analysis were carried out as described in the general methods section.
A Southern blot analysis of total DNA from pHAG3-l-derived Abade transformants is shown in figure 13- Restriction enzyme Cial does not have a recognition site in pHAG3~l. Digestion of non-transformed Abade DNA with CZαl and hybridization with the AbGH3~probe yields a 3-5 kb band, corresponding to the endogenous AbGH3 sequence plus flanking genomic sequences (Figure 13A, lane 3)- In transformant C25-1.15/3 this band has shifted to a higher position, indicating that the pHAG3-l DNA has integrated into the homologous AbGH3 sequence in C25-1 (Figure 13A, lane 11). This is not the case for transformant ClO-1.15/3, which still shows the endogenous 3-5 kb band, in addition to a higher band, which corresponds to the pHAG3~l sequences integrated ectopically (Figure 13A, lane 7) . Both high-position bands in lanes 7 and 11 also hybridize to the hpt-probe (Figure 13B) , confirming that they contain pHAG3_l sequences. Both Kpnl and Bglll have only one recognition site in pHAG3~l and the former was used to linearize the plasmid before transformation. Digestion of ClO-1 and C25-1 DNA with these enzymes yields 9>8 kb bands hybridizing to the hpt-probe (Figure 13B, lanes 8, 9. 1 and 13), plus additional bands representing border fragments containing adjacent genomic DNA. The plasmid sized bands of 9.8 kb indicate that in both ClO-1 and C25-1
tandem copies of pHAG3-l are present. After EcoRI digestion of ClO-1 and C25-1 DNA two hybridizing bands of expected length appear with the hpt- probe, which indicate the intactness of the GPD-promoter region and the hpt-gene in the transformants (Figure 13B, lanes 10 and 14). Hybridization with the AbGH3 probe yields two different bands of 3«2 kb, corresponding to the endogenous AbGH3 sequence (Figure 13A, lane 6) , and of 5.9 kb in the transformants (Figure 13A, lanes 10 and 14). The presence of the 5-9 kb band provides further evidence for the integration of tandem copies of pHAG3-l in both transformants. Homologous integration has occurred with high efficiency (in 2 out of four transformants analyzed) when driven by the AbGH3~sequence. The mechanisms involved during integration (of pHAG3-l) are not yet fully understood, but both in vivo ligation and double strand break repair seem to be involved.
Transformation of Abade using plasmid pHAG3~l, linearized with Kpnl inside the region of homology with A. bispovus DNA, can give rise to homologous integration of the plasmid into the endogenous AbGH3 region. This phenomenon occurs with high efficiency (50%) . In the cases of both homologous and ectopic integration investigated here, tandem copies of the integrated plasmid were found. Furthermore, in both instances the Kpnl-site was restored. Mechanisms resembling double strand break repair and in vivo ligation are involved.
Example 14: Southern blot analysis of total DNA from pHAG3-l derived Abade transformants derived from pHAG3-l and mated with Ul derived protoclones
Forced mating products were produced from strains indicated in the legend to figure 14 as described in the general methods section, in example 5 and figures 5A and 5B. The mating products were further propagated with no selective pressure on MMP agar medium (plus a sheet of cellophane) to isolate the total DNA for Southern blot analysis as described.
The luminograph of figure 14 shows the aberrant position of the AbGH3/ClαI-fragment of transformant C25-1/4/12 (lane 6). Lanes 12 - 15 comprise the DNA from different mating products with this transformed strain. Either nuclear type was clearly present in the combinations with Ulp6 and Ulpδ, although the Ulpδ nucleus seems to be under-represented in C25~l/Ulp8. Over-exposure (not shown) also revealed weakly hybridizing material at the 3-5 kb position in lanes 14 and 15. These results demonstrate that by the forced mating procedure described, in two out of
four mating products analyzed the presence of both participating nuclei can be identified. It may be significant to note that the colony morphologies of mating products between Abade transformants and Ul- derived protoclones was intermediate between the two parental strains with no tendency to form hyphal aggregates or sectors. The same type of morphology was also obtained after fusion of protoplasts from Abade transformants and from Ul, followed by double selection (SD agar medium with no adenine, with hygromycin, 50 μg.mL"1). Abade transformants DlO-l and C25~l were also mated with protoclones from strain B131 (T.J. Elliot; ATCC36974) which is characterized by the frequent formation of 4-spored basidia. The combination with B131-protoclones allows the isolation of transgenic homokaryotic spores. A variety of new morphologies was observed after forced matings between B131-protoclones and Abade transformants on double selective medium and further propagation on MMP agar medium, including the formation of hyphal aggregates, which is also observed during early fruitbody formation. Fruitbody initiation has been started with these mating products.
The forced mating procedure described here can yield mating products in which the presence of either nuclear type can be -demonstrated. In addition, unequal distribution or segregation of either one of the parental nuclei can be followed in time.
Example 1 Southern blot analysis of Abade transformants of pAlH or pUlH. Plasmids pUlH and pAlH were constructed as described and linearized with EeoRI before electroporation of Abade protoplasts. Southern blot analysis was carried out as described in the general methods section.
A preliminary comparison with the transformation vectors described before, showed that the new pAlH and pUlH constructs, both containing A. bispovus GPD2-promoter sequences resulted in a 2 - 10 fold increase of the transformation efficiency of Abade protoplasts. Figure 15 shows that also the new constructs have been integrated into the recipient DNA. In the four transformants shown hybridizing bands of 2.1 kb were present, representing the EcoRI/BαmHI-fragments of the new "constructs that comprise the 1.05 kb GPD2- plus 1.04 kb hpt-fragments.
In five transformants analyzed in more detail (results not shown) no homologous integration had occurred through the homologous GPD2-sequence (1.05 kb) , indicating that additional factors specify the occurrence or lack of homologous integration, e.g. the nature and/or the length of the
homologous insert and/or the presence of a new EcoRI-site introduced at the 5'-end of the GP-D2-promoter region by PCR (in order to allow cloning and later linearization before electroporation) .
Figure 15 shows a Southern blot analysis of DNA from Abade transformants, obtained after transformation with plasmids pAlH or pUlH containing A. bispovus GPD2-promoter sequences. The new pAlH and pUlH transformation constructs allow the direct selection of hygromycin- resistant transformants from Abade with a somewhat increased efficiency. The GPD2-sequence containing vector does not integrate at the homologous position as efficiently as the vector that comprises the AbGH3~sequence (PHAG3-1).
Example 16: Southern blot analysis of an Abade cotransformant
Transformation of Abade was performed as described in the general methods section with a mixture of plasmids pAN7~l and pUT720, both linearized with Hindlll. Transformant D20-1.14/6 was selected by growth on hygromycin-containing medium. DNA was isolated and Southern blot analysis was performed as described in the general methods section.
Figure 16 shows a Southern blot analysis of total DNA from Abade co- transformant D20-1.14/6. Digests with Ncol/BamEl and EcoRI/Bα HI of the DNA from D20-1.14/6 (lanes 15 and 16) show the same patterns as the plasmid controls pAN7-l (lanes 2 and 3) and pUT720 (lanes 5 and 6) after hybridization with the hpt-probe (figure 16A) and the JbZe-probe (figure 16B) , respectively. This indicates the presence of both hpt- and ble- sequences in D20-1. This is further demonstrated by the combination of patterns visible in figure 16C (hpt- and e-probes) . Digestion with Hindlll (lane 17) yields plasmid sized bands with both probes, indicating that the Hindlll-sites of the linearized plasmids were restored upon integration in the Agavicus genome. Digestion with EcoRV (lane 18) , which does not cut either plasmid, yields one band hybridizing to both probes (figure 16C) , suggesting co-integration of pAN7~l and pUT720 at one genomic site.
Co-transformation of A. bispovus is possible. In the co-transformant studied in detail, it appears that the Hindlll-sites, which were used for linearization of the plasmids prior to transformation, are restored e.g. by ligation of the plasmids before integration. Furthermore, the hybridization patterns observed are in agreement with integration of both plasmids at the same site in the genome.
Example 17: Effect of substrate composition on fruitbody formation.
Fruitbodies were produced from commercial strain Ul according to the protocol described in the general methods section. This time the experiments were performed in 500 mL jars, now with 25 grams of grain kernels that were inoculated with the amount of mycelium from one cellophane-covered MMP agar plate and, after colonization, with 50 grams of compost or hemp core tissue. Other handlings were in principle the same as described before.
Figure 17 shows the effect of substrate composition on the efficiency of small scale fruitbody formation. With this protocol for A. bispovus fruitbody production from strain Ul, normally one fruitbody emerged and developed while primordia already present did not develop until the older fruitbody was removed (jar 1). Replacing the compost by hemp tissue resulted in the same type of fruitbody development (jar 2). However, with increasing amounts of added freeze-dried and finely ground compost (1% and 10% in jars 3 and 4, respectively) increasing numbers of primordia developed into fruitbodies. These results indicate that by mechanically releasing compounds from commercially available compost, which are present but not (easily) accessible to the growing mycelium, fruitbody initiation and/or development can be improved. This implies that providing A. bispovus with more or better enzyme activities suitable for the degradation of essential compost constituents (e.g. by co- transformation) may increase fruitbody yields.
Moreover, these results suggest that the production of mushroom fruitbodies can be applied for the bio-degradation of agro-waste materials (such as hemp core tissue) . This system may be improved by the production of A. bispovus transformants that comprise suitable added genes.
Mushroom fruitbodies can be produced on alternative substrates. The system can be improved by the addition of compost-borne components that can be released mechanically (or perhaps enzymatically) .
Example 18: Northern blot analysis of Abade transformants of pHAG3-l, pAlH and pUlH Transformant C25-1.4/12 was obtained from Kpnl-digested plasmid pHAG3-l. Transformants ElO-1.28/3, E20-1&2.28/3 and F10-1&2.28/3, were obtained from plasmids pAlH and pUlH, respectively, both digested with EcoRI. Total RNA was isolated from freeze-dried mycelium and Northern blot analysis was performed using standard procedures.
Total RNA was extracted and electrophoresed as described in the general methods section.
The results shown in figure 18 indicate that in A. bispovus transformants obtained with a pAN7-l-derived construct, two transcripts are generated which are full-length (arrows a and b, also occurring in A. nigev strains transformed with pAN7-l, data not shown), whereas other transcripts are too short to yield full-length translation products (arrows c and d) . The generation of two full-length mRNA products (a and b) may be explained by the two different termination signals, separated by about 250 bp, which are present in the A. nidulans TRPC-terminator sequence. Apparently, these are similarly recognized in A. bispovus . After long term propagation band c has disappeared for unknown reasons. Banding patterns from lanes 1 and 2 are representative for all transformants obtained with pAN7~l or its direct derivative (pHAG3~l) . "On the contrary, Abade transformants containing vectors which comprise the A. bispovus GP2)2-promoter sequence (and the modified hpt-gene) yield the normal transcripts also observed in A. nigev pAN7-l transformants.
Preliminary results indicate that with the new transformation construct a 2 - 10 -fold increase of the transformation efficiency was achieved in A. bispovus.
Using novel transformation vectors comprising the A. bispovus GPD2- promoter sequence (and the modified hpt-gene), the efficiency of A. bispovus transformation can be increased and the nature of hpt-specific transcripts normalized.
FIGURE LEGEND
Fig.l: Southern blot of undigested total DNA from eight 'Abade' transformants and controls. Lane 1, BαmHI-digested plasmid pAN7-l. Lane 2, Kpnl-digested plasmid pHAG3~l. Lanes 3_13. undigested total DNA extracted from untransformed 'Abade' (lane 3) and colonies AlO-1, A25-1, BlO-1, B25-2, C25-1, C25-2, D10- 1, D10-2, D10-3, D25-1 (lanes 4-13, respectively). The blot was hybridized to a DIG-labelled hpt-probe.
Fig.2: Southern blot of digested total DNA from four 'Abade' trans¬ formants. Lane 1, B^ZII-digested plasmid pHAG3~l. Lane 2, BαmHI-digested plasmid pHAG3~l. Lane 11, BαmHI-digested plasmid pAN7-l. Lane 12, EcoRI-digested plasmid pAN7-l. Lanes 3"10, digested total DNA from transformants C25-1 (lanes 3&4), C25-2
(lanes 5&6) , DlO-l (lanes 7&8) and D10-2 (lanes 9&10) . DNA's were digested with Bglll (lanes 3&5). BαmHI (lanes 4, 6, 7. 9) and EcoRI (lanes 8 & 10). The blot was hybridized to a DIG- labelled hpt-probe.
Fig.3: Schematic representation of the reconstruction of the wild-type E. coli hpt gene.
Fig.4A: Southern blot analysis of A. bispovus UlmplO-derived primary hygromycin B resistant transformants using a DIG-labelled hpt probe. Lanes 3_H contain undigested total DNA and lanes 12-20 contain EcoRV-digested DNA from non-transformed control UlmplO (lanes 3, 12) and transformants Bd25-1 (lanes 4, 13), Bb50-1 (lanes 5. 14), Bb50-2 (lanes 6, 15), Bb50~3 (lanes 7. 16) , BblOO-1 (lanes 8, 17), Bbl00-2 (lanes 9, 18) , Bbl00-3 (lanes
10, 19), Bbl00-4 (lanes 11, 20). Lanes 1, 22 : pAN7-l digested with BαmHI, lanes 2, 21: size marker, phage Lambda DNA digested with EcoRI and Hindlll.
Fig. 4B: Southern blot analysis of A. bispovus UlmplO-derived hygromycin B resistant sectoring transformants using a DIG-labelled hpt probe. Total DNAs were digested with EcoRI and BαmHI. Symbols, a,b,c: inocula taken from sectors that developed at the centre,
halfway or at the edge of the colony, respectively; p: plasmid pAN7-l digested with EcoRI and BαmHI.
Fig. 4C: Strain-specific fingerprints of BαmHI+EcoRI double-digested total DNA from UlmplO-derived hygromycin B resistant trans¬ formants, probed with a DIG labelled hpt probe. Lane 1: pAN7-l cut with BαmHI+EcoRI, lane 2: size-marker, phage Lambda DNA double-digested with EcoRI+HindIII, lanes 3~10: BαmHI+EcoRI double-digested DNAs from control non-transformed UlmplO and transformants Bd25-1, Bb50-1, Bb50-2, Bb50-3, BblOO-1, Bbl00-2, respectively.
Fig.5A,B: Dominant selection of a A. bispovus heterokaryon containing an ade/hyg-- (from C25-1) and a Ul-derived nucleus (from protoclone Ulpδ). A: SDO-medium (no hygromycin B) , with (I) or without
(II) adenine. B: SD50-medium (50 μg.mL"1 hygromycin B) , with (I) or without (II) adenine. Strain Ulpδ shows clear growth on SDO- medium, but unexpectedly thin, hardly visible growth in the presence of adenine. BII (double selective medium) shows continued growth of mated colonies (duplicate inocula in the middle), exclusively, whereas parental strains do not.
Fig. 6: PCR-analysis of Abade hygromycin-resistant transformants. Lanes 1, 10: phage Lambda digested with EcoRI and Hindlll; lanes 2 - 5 - template DNA isolated from non-transformed Abade control, transformants C25-1, DlO-1 and non-transformed Ul, exposed to A.bispovus GPD2 promoter-specific primers (AbGPDl, sequence id 7, AbGPD2c, sequence id 9) 5 lanes 6 - 9: template DNA from non- transformed Abade control, transformants C25-1, D10-1 and pAN7- 1, respectively, exposed to hpt-specific primers (PR-HPT1, encompassing ATG at position 1: '-ATG.AAA.AAG.CCT.GAA.CTC.ACC.GCG.ACG.TCT-3' , sequence id 10 and PR-HPT2c [complement], encompassing TAG around position 1050: 3'-GGG.TCG.TGA.GCA.GGC.TCC.CGT.TTC.CTT.ATC-5' , sequence id 11)
Fig. 7: Southern blot analysis of fruitbodies derived from UlmplO primary transformants, hybridized to a DIG-labelled hpt-probe.
All DNAs were digested with BαmHI plus EcoRI. Lane 1: pAN7-l; lane 2: Ul; lanes 3 - δ: transformants Ulmpl0/Bb50-1 (vav. Miranda) , UlmplO/Bb50-3 (vav. Paula) , UlmplO/BblOO-1 (vav. Nicole) , unstable transformant UlmplO/BblOO-2 (vav. Nonna) , Ulmpl0/Bbl00-3 (vav. Nadine), Ulmpl0/Bbl00-4 (vav. Febeline) , respectively, kb, kilobase pairs.
Fig. δA, B, C:
Southern blot analysis of total DNA from matings between primary Abade transformants and Ul-derived protoclones, hybridized to a DIG-labelled hpt-probe. All DNAs were digested with BαmHI plus EcoRI. 8A, 8B, 8C: generation 1, 2 and 3. respectively. Lanes 1 - 18: DlO-1, C25-1, Ulp6, Ulp6/D10-1,
Ulp6/C25-1, Ulpδ, Ulp8/D10-1, Ulp8/C25-1, Ulpl2, Ulpl2/D10-1, Ulpl2/C25-1, Ulpl5, Ulpl5/D10-1, Ulpl5/C25-1, Ulpl6, Ulpl6/D10-
1, Ulpl6/C25-1, Abade, respectively and lane 19: pAN7-l. kb, kilobase pairs.
Fig. 9A, B, C: Southern blot analysis of total DNA from an Abade-derived hpt/bZe-cotransformant D20-1, hybridized to DIG-labelled probes: A, hpt-probe; B, bZe-probe and C, mixed hpt/fcZe-probe. Lane 1: pAN7~l digested with EcoRI plus BαmHI (2.3 kb band hardly visible); lanes 2 and 3 pUT720 digested with EcoRI and EcoRI plus BαmHI, respectively; lane 4: phage Lambda (digested with EcoRI plus Hindlll, not hybridizing); lanes 5. 6 and 7 total DNA from D20-1 digested with Ncol , B mHI or Hindlll, respectively. Non-transformed Abade control did not hybridize (not shown), kb: kilobase pairs.
Fig. 10: Production of homokaryotic protoclones from primary heterokaryotic transformants. Hygromycin-resistance was tested of Ulmpl0/Bbl00-1 (vav. Nicole)-derived protoclones grown on DTδO agar medium containing 50 μg.mL"1 hygromycin. A4: non- transformed UlmplO control, B3: negative protoclone which has lost the hygromycin-resistance (growth without hygromycin was same as others, not shown).
Fig. 11: PCR-analysis of donor DNA hpt- and LUC-markers after re- extraction from electroporated Ul protoplasts-. Lane 1: donor DNA mixture containing plasmids pAN7-l (hpt) and pT3T7-luc (LΪ7C) ; lane 2: re-extracted DNA after extensive washing plus DNAse I-treatment of protoplasts; lane 3 re-extracted DNA after extensive washing of protoplasts, only. DNA samples serving as PCR-templates were exposed simultaneously to hpt- specific primers PR-HPT1 (encompassing ATG at position 1: sequence id 10) and PR-HPT2c (complement, encompassing TAG around position 1050: sequence id 11) and LtC-specific primers PR-LUC-1 (encompassing ATG at position 304: sequence id 12) and PR-LUC-2c (complement, encompassing position I896: sequence id 13). Panel A, B: 15, 20 PCR-cycles, respectively.
Fig. 12: Northern blot analysis of RNA extracted from fruitbodies produced from UlmplO-derived primary transformants. Lane 1: RNA from mycelium of control Abade transformant D10-2; lane 2: RNA from non-transformed Ul-fruitbodies; lane 3 "5 lane 4: RNA from Ulmpl0/Bb50-1 fruitbodies and lane 5 same strain harvested 4 days later. The arrow indicates the position of the major transcript detected in A. nigev (pAN7-l)-transformants, corresponding to about 1450 nucleotides.
Fig. 13A, B:
Southern blot analysis of total DNA from pHAG3~l-derived Abade transformants, using DIG-labelled AbGH3~ (A) or hpt-probes (B) . Lane 1: mixture of pHAG3~l digested with B^ZII or BαmHI; lane 2: mixture of non-digested and Hindlll-digested phage Lambda DNA (not hybridizing); lanes 3 - 6: Abade non-transformed control DNA digested with CZαl, Kpnl, Bg-ZII or EcoRI, respectively; lanes 7 - 10: DNA from Abade transformant C10- 1.15/3 and lanes 11 - 14: DNA from Abade transformant C25- 1.15/3. also digested with CZαl, Kpnl, Bglll or EcoRI, respectively, kb: kilobase pairs.
Fig. 14: Southern blot analysis of total DNA from pHAG3-l-derived Abade transformant C25-1.4/12 (showing homologous integration through the AbGH3~sequence) , mated to Ul-derived protoclones and
hybridized to a DIG-labelled AbGH3-probe. All A. bispovus genomic DNAs from controls and mating products were digested with CZαl. Lanes 1 and 2: pHAG3~l digested with Bg-ZII or Hindlll, respectively; lane 3 phage Lambda DNA digested with Hindlll plus EcoRI (not hybridizing); lane" 4 and 5 non- transformed Abade and Ul control DNAs; lane 6: DNA from Abade transformant C25-1.4/12; lanes 7 - 11: DNA from Ul-protoclones Ulp6, Ulpδ, Ulpl2, Ulpl5 and Ulpl6, respectively; lanes 12 - 15: mating products between C25-1.4/12 and Ulp6, Ulpδ, Ulpl2 and Ulpl5, respectively, kb: kilobase pairs.
Fig. 15: Southern blot analysis of DNA from Abade transformants, obtained after transformation with plasmids pAlH or pUlH containing A. bispovus GPZ>2-promoter sequences from Abade or Ul, respectively and the modified hpt-gene. Genomic DNAs were digested with EcoRV (odd numbered lanes) or with EcoRI plus BαmHI (even numbered lanes) and hybridized to a DIG-labelled hpt-probe. Lanes 1 and 2: non-transformed Abade control; lanes 3 and 4: transformant E10-1.26/3; lanes 5 and 6: transformant E20-1.26/3; lanes 7 and δ: transformant E20-2.26/3; lanes 9 and
10: transformant F10-2.2δ/3. kb: kilobase pairs; 2.1 kb, representing the EcoRI/BαmHI-fragments from pAlH and pUlH hybridizing to the hpt-probe.
Fig. 16A, B, C:
Southern blot analysis of total DNA from Abade co-transformant D20-1.14/6 (simultaneously transformed with pAN7-l and pUT720) , hybridized to DIG-labelled probes: hpt-probe (A), bZe-probe (B) and mixed hpt-/i>Ze-probes (C). Lane 1: phage Lambda digested with EcoRI plus Hindlll (not hybridizing); lanes 2, 3. and 4: pAN7-l, digested with iVcoI plus BαmHI, EcoRI plus BαmHI and with BαmHI, respectively; lanes 5. 6 and f : pUT720, digested with iVcoI plus BαmHI, EcoRI plus BαmHI and with BαmHI, respectively; lane δ: pABAGL-1 digested with EcoRI plus Ncol (not hybridizing); lane 9 ". lanes 10 - 14: non-transformed
Abade control, digested with Ncol plus BαmHI, EcoRI plus BαmHI, Hindlll, EcoRV or Hindlll plus EcoRV (not hybridizing); lanes 15 - 19: D20-1.14/6, digested with Ncol plus BαmHI, EcoRI plus BαmHI, Hindlll, EcoRV or Hindlll plus EcoRV; kb: kilobase
4δ pairs, sizes 6.0, 2.6 and 0.4 represent specific pUT720- fragments.
Fig. 17A, B:
Effect of substrate composition on the efficiency of small scale fruitbody formation. A: view from above, B: view from the side. Grain kernels colonized with A. bispovus mycelium were mixed with the substrates indicated. Jar 1: commercially available ready to use compost; jar 2, 3 and 4: hemp (Cannάbis sativa) core tissue, remaining after removal of bast tissue, mixed with 0%, 1% and 10% (w/w) freeze-dried and finely ground compost.
Fig. lδ: Northern blot analysis of total RNA from Abade hygromycin- resistant strains, transformed with pHAG3~l (A. nidulans GPD- promoter and non-modified hpt-gene) , pAlH or pUlH (containing A. bispovus Abade or Ul GPZλ2-promoter-sequences plus the modified hpt-gene described above) , hybridized to a 3P-dCTP- labelled hpt-probe. Lane 1: Abade; lanes 2 and 3: pHAG3~l transformant C25-1.4/12, RNA from lane 2 and 3 isolated after 10 generations and after 4 generations, respectively; lane 4 - δ: pAlH- transformants E10-1.26/3, E20-1.2δ/3, E20-2.26/3 and pUlH-transformants F10-1.26/3, F10-2.2δ/3, respectively. Arrows indicate the positions of major transcripts.
Approximate sizes: a, b, c and d, 1700 , 1450, 900, 400 nucleotides, respectively, as deduced from a co-electrophoresed Gibco BRL 0.17 - 1.77 kb size marker.
Fig 19A, B, C:
Restriction maps of plasmids pHAG3_l (A) , pAnHB (B) and pAnHL (C). Abbreviations: Bm, BαmHI; Bg, BσZII; E, EcoRI; ERV, EcoRV; H, Hindlll; K, Kpnl; Nc, Ncol; Nh, Nhel; No, Notl ; X, Xbαl; ble , phleomycin-resistance gene; hpt , hygromycin- phosphotransferase gene; LUC, Photinus pyvalis (firefly) luciferase gene; ATG. start codons; PGPD, TTRPC, A. nidulans GPD- promoter- and TRPC-terminator-sequences, respectively; ssa, excretion signal sequence of the Tvichodevma veesei cellobiohydvolase I-gene. Essential ble- , hpt- and LUC-coding
sequences in grey. Numbers refer to approximate positions (bp) . Individual drawings and DNA segments not to the same scale.
REFERENCES
Alic M, Kornegay JR, Pribnow D, Gold MH (19δ9) Appl Env Microbiol 55: 406-411
Banks GR, Kanuga N, Ealing J, Spanos A, Holden DW (1992) Curr Genet 22 \
483-489 Binninger DM, Skrzynia C, Pukkila PJ, Casselton LA (1987) The EMBO J 6:
835-840 Castle AJ, Horgen PA, Anderson JB (1988) Appl Environm Microbiol 54:
1643-1646 Challen MP, Rao BG, Elliot TJ (1991) In:
Genetics and breeding of Agaricus. Proceedings of the
First International Seminar on Mushroom Science. LJLD van Griensven (ed.). Pudoc, Wageningen, The Netherlands. Pp 135-139
Chater K. Saps, hydrophobins and aerial growth. Curr Biol 1 (1991)
318-320 Dijkstra FY (1976) PhD thesis, University of Delft, The Netherlands Faber KN, Swaving GJ, Faber F, Ab G, Harder W, Veenhuis M, Haima P. (1992) J Gen Microbiol 138: 2405-2416
Fincham JRS (19β9) Microbiol Rev 53: 146-170
Fritsche G Maintenance (1991) . rejuvenation and improvement of Horst® Ul
In: Genetics and breeding of Agaricus. Proceedings of the First
International Seminar on Mushroom Science, LJLD van Griensven (ed) Pudoc, Wageningen, The Netherlands. Pp 145-160 Gausing K (19δ7) Planta 171: 241-246 Gritz L, Davies J (19δ3) Gene 25: 557"5δO Harmsen MC, van Griensven LJLD, Wessels JGH (19δ9) J Gen Virol 70:
1613-1616 Harmsen MC, Tolner B, Kram A, Go SJ, de Haan A, Wessels JGH (1991) Curr
Genet 20: 137-144 Hiatt A, (1990) Nature 344: 469-470 Horgen PA, Jin T, Anderson JB (1991) In:
Genetics and breeding of Agaricus. Proceedings of the First International Seminar on Mushroom Science. LJLD van Griensven (ed.).
Pudoc, Wageningen, The Netherlands. Pp 62-72 Kay E, Vilgalys R (1992) Mycologia 64: 173"lδ2 Khush RS, Morgan L, Becker E, Wach M (1991) In:
Proceedings of the First International Seminar on Mushroom Science,
Mushroom experimental Station, Horst, The Netherlands. LJLD van
Griensven (ed.) Wageningen, Pudoc III. Pp 73"8θ Lerch K, (1982) J. Biol. Chem. 257: 64l4-64l9 Liou CM, Yanai K, Horiuchi H, Takagi M
(1992) Biosci Biotech Biochem 56: 1503-1504 Maniatis T, Fritsch EF, Sambrook J
(1982) Molecular cloning: A laboratory manual. Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY Mooibroek H, Sietsma JH, Wessels JGH
(19δ7) Abstracts 19th Lunteren Conference on Molecular Genetics, p52 Mooibroek H, Kuipers AGJ, Sietsma JH, Punt PJ, Wessels JGH
(1990) Mol Gen Genet 222: 41-48 Munoz-Rivas A, Specht CA, Drummond BJ, Froeliger E, Novotny CP, Ullrich RC (1986) Mol Gen Genet 205: 103-106
Murashige T, Skoog F (1962) Physiol Plant 15: 473-497 Nishiyama Y, Nakayama S, Okada Y, Min K-S, Onosaka S, Tanaka K
(1990) Chem Pharm Bull 38: 2112-2117 Peng M, Singh NK, Lemke PA (1992) Curr Genet 22: 53-59 Plϋckthun A, (1990) Nature 347: 497-498
Punt PJ, Oliver RP, Dingemanse MA, Pouwels PH, van den Hondel CAMJJ
(1987) Gene 56: 117-124
Raeder U, Broda P (1985) Microbiology 1: 17-20 Raguz S, Yague E (1991) In: Science and cultivation of edible fungi, Maher ed.) Balkema Rotterdam, ISBN 9054100214, pp 43-50 Randall TA, Reddy CA (1992) Curr Genet 21: 255-260 Raper CA, Raper JR, Miller RE (1972) Mycologia 64: 1008-1117 Raper CA (1988) Schizophyllum commune , a model for genetic studies of the Basidiomycetes. In: GS Sidhu (ed.): Genetics of plant pathogenic fungi. Academic Press, London, p511_522 Royer JC, Horgen PA (1991). In:
Genetics and breeding of Agaricus. Proceedings of the First International Seminar on Mushroom Science. LJLD van Griensven (ed.). Pudoc, Wageningen, The Netherlands. Pp 135-139 Sonnenberg AS, Wessels JG, van Griensven LJ
(1988) Curr Microbiol 17: 285-291
Stringer MA, Dean RA, Sewall TC, Timberlake WE. Rodlet-less, a new
Aspevgi llus developmental mutant induced by direct gene inactivation. Genes Dev. (1991) H6I-II7I Tsai H-F, Siegel MR, Schardl CL (1992) Curr Genet 22: 399-406 Wang J, Holden DW, Leong SA (1988) Proc Natl Acad Sci USA 65: 865-869 Wessels JGH, de Vries OMH, Asgeirsdottir SA, Springer J. The thn mutation of Schizophyllum commune , which suppresses formation of aerial hyphae, affects expression of the Sc3 hydrophobin gene. J. Gen.
Microbiol 137 (1991a) 2439-2445 Wessels JGH, de Vries OMH, Asgeirsdottir SA, Schuren FHJ. Hydrophobin genes involved in formation of aerial hyphae and fruit bodies in
Schizophyllum. The Plant Cell 3 (1991b) 793-799 Wood DA, Claydon N, Burton KS, Matcham SE, Allan M, Perry C, Thurston CF,
Raguz S, Yague E (1991) In: Science and cultivation of edible fungi, Maher (ed.) Balkema Rotterdam, ISBN 9054100214, pp 43-50.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT:
(A) NAME: ATO-DLO Instituut voor Agrotechnologisch
Onderzoek
(B) STREET: Haagsteeg 6 (C) CITY: Wageningen
(D) STATE: Gelderland
(E) COUNTRY: The Netherlands
(F) POSTAL CODE (ZIP): 6708 PM
(A) NAME: CNC Cooperatieve Nederlandse
Champignonkwekersvereniging B.A.
(B) STREET: Driekronenstraat 6
(C) CITY: Milsbeek
(E) COUNTRY: The Netherlands (F) POSTAL CODE (ZIP) : 6596 MA
(ii) TITLE OF INVENTION: Production and application of transgenic mushroom mycelium and fruitbodies
(iii) NUMBER OF SEQUENCES: 13
(iv) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: Patentln Release #1.0, Version #1.25 (EPO)
(2) INFORMATION FOR SEQ ID NO: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 21 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE:
(B) CLONE: Nco-HPT5
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:
GACATCACCA TGGCTGAACT C 21
(2) INFORMATION FOR SEQ ID NO: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 21 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE:
(B) CLONE: AnTRPC3C
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
CCGCTCGAGT GGAGATGTGG A 21
(2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 20 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE: (B) CLONE: HPT-E2
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
AGTTCAGCGA GAGCCTGACC 20
(2) INFORMATION FOR SEQ ID NO: 4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 20 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE:
(B) CLONE: HPT-NTC
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:
CATAGCCTCC GCGACCGGCT 20
(2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 35 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE: (B) CLONE: EN-LUC-1
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:
GGGAATTCCA TGCCATGGAA GACGCCAAAA ACATA 35
(2) INFORMATION FOR SEQ ID NO: 6:
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ϋ) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE: (B) CLONE: T7
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
TAATACGACT CACTATAGGG 20
(2) INFORMATION FOR SEQ ID NO: 7:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single (D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE: (B) CLONE: AbGPDl
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7':
GGAATTCGTT GTCATCACCG CTCCTGGGAG 30
(2) INFORMATION FOR SEQ ID NO: 8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE: (B) CLONE: AbGPD3
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:
GAAGAAGAAT TCAGAGGTCC GCAAGT 26
(2) INFORMATION FOR SEQ ID NO: 9:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(iii) ANTI-SENSE: NO
(vii) IMMEDIATE SOURCE: (B) CLONE: AbGPD2c
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:
GCTTATCGCC ATGGTTTGTC TCTC 24
(2) INFORMATION FOR SEQ ID NO: 10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE: (B) CLONE: PR-HPT1
(xi) SEQUENCE DESCRIPTION: SEQ ID NO 10:
ATGAAAAAGC CTGAACTCAC CGCGACGTCT 30
(2) INFORMATION FOR SEQ ID NO: 11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE: (B) CLONE: PR-HPT2c
(xi) SEQUENCE DESCRIPTION: SEQ ID NO 11:
GGGTCGTGAG CAGGCTCCCG TTTCCTTATC 30
(2) INFORMATION FOR SEQ ID NO: 12:
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE:
(B) CLONE: PR-LUC-1
(xi) SEQUENCE DESCRIPTION: SEQ ID NO 12:
ATGGAAGACG CCAAAAACAT AAAGAAAGGC 30
(2) INFORMATION FOR SEQ ID NO: 13:
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(vii) IMMEDIATE SOURCE:
(B) CLONE: PR-LUC-2c
(xi) SEQUENCE DESCRIPTION: SEQ ID NO 13:
CACCGGGGCC GACTTAACCT TAGCTATAAC 30
Claims (36)
1. A method for obtaining a selectable stable transformant of a homo¬ basidiomycete capable of expressing integrated donor DNA comprising at least a dominant selectable marker at a detectable level, wherein said host is optionally non-auxotrophic and can be transformed without co- transformation with said dominant selectable marker and is transformed with said donor DNA.
2. A method according to claim 1, wherein the host to be transformed exhibits delayed differentiation in comparison either to non-protocloned homobasidiomycete material and/or the wild type strain Ul as obtainable from ATCC, said delayed differentiation being macroscopically visible in the form of amended morphology due to a change in the number and/or height of aerial hyphae, preferably by the absence of aerial hyphae and/or a diminished hyphae aggregate formation preferably by the absence of hyphae aggregates.
3. A method according to claim 1 or 2 wherein the host to be transformed belongs to the strain 'Abade' .
4. A method according to any of the preceding claims, wherein the host to be transformed is obtained by subjecting homobasidiomycete material to protocloning followed by selection of resulting homobasidiomycete material exhibiting the desired delayed differentiation.
5. A method according to any of the preceding claims wherein the host to be transformed is obtained by subjecting homobasidiomycete material to a rejuvenation procedure followed by selection, of resulting homobasidiomycete material exhibiting the desired delayed differentiation.
6. A method for obtaining a dominant selectable stable transformant of a homobasidiomycete capable of expressing integrated donor DNA at a detectable level according to claim 4 or 5. said method comprising a) subjecting the mycelium of the host to be transformed to at least:
1) protoplast formation, followed by
2) an outgrowth phase to colonies, followed by 3) isolation of individual protoclones resulting from step 2, followed by
4) an outgrowth phase to colonies followed by
5) a selection of a protoclone resulting from- step 4 on the basis of exhibiting delayed differentiation in comparison either to non-protocloned homobasidiomycete material and/or the wild type strain Ul as obtainable from ATCC, said delayed differentiation being macroscopically visible in the form of amended morphology due to a change in the number and/or height of aerial hyphae, preferably by the absence of aerial hyphae and/or a diminished hyphae aggregate formation preferably by the absence of hyphae aggregates followed by
6) optionally at least one cycle of further propagation of a selected clone including a subsequent outgrowth phase to colonies and cultivation preferably in liquid medium
7) at least one protoplast formation step from such a colony and subsequently b) subjecting protoplasts resulting from step 7 to transformation with donor DNA.
7. A method according to any of the preceding claims, wherein the transformation procedure occurs within 25 outgrowth phases of the detection of the delayed differentiation, preferably within 5 outgrowth phases, wherein an outgrowth phase corresponds to the growth of one clone on an agar plate of 9 cm until the plate is full
δ. A method according to claim 6 or 7. wherein the protoplast to be used for transformation in step b has not been subjected to more than successive outgrowth phases in step 6.
9. A method according to any of the preceding claims, wherein the host homobasidiomycete is a homokaryon.
10. A method according to any of the preceding claims, "wherein the host homobasidiomycete belongs to A. bispovus strains Ul or 'Abade'.
11. A method according to any of the preceding claims, wherein the method of transformation is electroporation.
12. A method according to any of the preceding claims, wherein the donor DNA is linearized prior to transformation.
13. A method according to any of claims 6-12, wherein the protoplast formation step is improved by growth of mycelium in plant medium for cultivation and regeneration of plant cells, e.g. MS-medium, in particular for a host belonging to the genus Agavicus immediately preceding step 7 of protoplast formation.
14. A method according to any of the preceding claims, wherein the transformation is carried out using donor DNA comprising at least a vector comprising a selection marker encoding resistance to an antibiotic and/or a fungicide for which the non-transformed host is sensitive.
15. A method according to claim 14, wherein the donor DNA comprises nucleic acid capable upon expression thereof of rendering the host resistant to hygromycin as selection marker, said nucleic acid for example comprising the hpt gene of E. coli or Streptomyces or a modified derivative thereof providing increased resistance to hygromycin than the wild type hpt gene, preferably of E. coli .
16 A method according to any of the preceding claims, wherein the donor DNA further comprises a nucleotide sequence sufficiently homologous to a part of the DNA of the host to be transformed and sufficiently long to enable homologous integration to occur.
17. A method according to any of the preceding claims, wherein the donor DNA further comprises a promoter, preferably a strong promoter and optionally a terminator sequence homologous to the host to be transformed.
18. A method according to any of the preceding claims, wherein the donor DNA comprises a GDP-2 promoter of A. bispo-cus .
19. A method according to any of the preceding claims comprising co- transformation of the donor DNA with other DNA comprising at least one further desirable sequence for transforming the host, said donor DNA and other DNA preferably being linearised and comprising termini capable of ligating to eachother, thereby linking the donor DNA to the other DNA.
20. A method according to any of the preceding claims, wherein the host material belongs to the strain Abade and is plated out on DTδO medium after regeneration and prior to selection.
21. A method according to any of claims 1-19. wherein the host material belongs to the strain UlmplO and is plated out on B5 medium after regeneration and prior to selection.
22. A method according to any of the preceding claims, wherein the regeneration time prior to transformation comprises at least three days, preferably in CMPS medium.
23. A method for production of homokaryotic transformants from primary heterokaryotic transformants obtainable via the method of any of claims 1-22, preferably by protocloning.
24. A method for production of stable transgenic fruitbodies from primary transformed heterokaryotic material wherein at least one of the nuclei of the heterokaryotic material is transformed in a manner according to any of claims 1-22.
25. A method for production of stable transgenic fruitbodies comprising mating two compatible strains wherein at least one of the mating strains is a transformant obtainable from a method according to any of claims 1- 23.
26. A method for production of stable transformants of homobasidiomycetes, comprising mating two compatible strains, wherein one of the mating strains is a transformant obtainable from a method according to any of claims 1-23 and the other mating strain comprises a further selectable marker different to the selectable marker of the transformant.
27. A method according to claim 25 or 26, wherein the transformant used in the mating is a transformant of the strain 'Abade' and said transformant comprises an adenine deficiency (as does the non transformed strain 'Abade' ) and resistance to hygromycin B due to the presence of donor DNA.
28. A method according to claim 27. wherein the other mating strain is not deficient for adenine and is sensitive to hygromycin B, resulting in selectability of the product of said mating on lack of adenine deficiency and resistance to hygromycin B.
29. A method according to any of claims 25-28, wherein said mating com¬ prises naturally occurring anastomosis or artificial protoplast fusion.
30. A method of providing a genetic fingerprint specific for a trans- formed homobasidiomycete comprising DNA analysis of a transformant or transgenic fruitbody obtainable through a method according to any of the preceding claims.
31. A method according to claim 30, wherein a genetic fingerprint specific for heterokaryotic material resulting from a method of mating according to any of claims 25-29 can be determined distinguishing said heterokaryotic material from the homokaryotic transformant used as mating strain either by analysing for the presence of more genetic material in the heterokaryotic material than in the homokaryotic transformant and/or when the second mating strain comprises different genetic material than the transformant mating strain by analysis of the RFLP, RAPD or isozyme band pattern of the resulting heterokaryotic material.
32. Non-auxotrophic transgenic homobasidiomycete material derived from a non-auxotrophic homobasidiomycete, said transgenic material comprising stably integrated donor DNA comprising a dominant selectable marker such as a resistance to antibiotic and said transgenic material further being capable of expressing said donor DNA in an amount sufficient to ensure selectability over the corresponding non transgenic material.
33- Auxotrophic transgenic homobasidiomycete material derived from a auxotrophic homobasidiomycete, said transgenic material comprising stably integrated donor DNA comprising a dominant selectable marker such as a resistance to antibiotic and said transgenic material further being capable of expressing said donor DNA in an amount sufficient to ensure selectability over the corresponding non transgenic material.
34. A vector suitable for transforming homobasidiomycete material in particular A. bispovus , said vector comprising the GPD-2 promoter sequence operationally connected to a selection marker encoding resistance to an antibiotic and/or a fungicide for which the host to be transformed is sensitive.
35« A vector suitable for transforming homobasidiomycete material according to claim 34 wherein said selection marker is the hpt gene of E. coli or Stveptomyces or a modified derivative thereof providing increased resistance to hygromycin in comparison to the wild type hpt gene.
36. A vector according to claim 34 or 35 further comprising a sequence homologous to a part of the chromosome of the host to be transformed of sufficient homology and length for homologous integration to occur, in particular comprising the A. bispoieus AbGH3 sequence or a portion thereof.
37- A vector according to any of claims 34-36 comprising the dominant selectable hpt marker, said vector obtainable by at least the following essential steps:
1) Introduction of an Neol-site comprising the methionine-encoding translation initiation codon of the hpt gene e.g. via the PCR method using the wild-type E. coli hpt-gene or plasmids pHRC or pAN7~l as templates and combinations of the following primers having seq. id 1, 2 as illustrated in the sequence listing.
2) Removal of the unique Ncol- and EcoRI-sites from the wild-type hpt coding region by in vitro mutagenesis e.g. via PCR using primers having sequence id 3 and 4.
3) Cloning of the fragment altered in steps 1 and 2 in a proper E. coli (e.g. pUC-based) vector.
4) Introduction of EcoRl/Ncol genomic fragments preferably from A. bispovus and optionally comprising promoter activity.
5) Introduction of BαmHI-Hindlll genomic fragments preferably from A. bispovus and not containing EcoRI- and/or Ncol-restriction sites, optionally comprising terminator activity.
6) Propagation of this plasmid DNA in a proper host preferably lacking or mutated for the capacity to restrict and/or modify cloned homobasidiomycete DNA.
3δ. Use of a vector according to any of claims 34-37 i a method according to any of claims 1-31-
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WONL9300149 | 1993-07-13 | ||
| NL9300149 | 1993-07-13 | ||
| PCT/NL1994/000164 WO1995002691A2 (en) | 1993-07-13 | 1994-07-13 | Production and application of transgenic mushroom mycelium and fruitbodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7509194A true AU7509194A (en) | 1995-02-13 |
| AU682057B2 AU682057B2 (en) | 1997-09-18 |
Family
ID=19861973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU75091/94A Ceased AU682057B2 (en) | 1993-07-13 | 1994-07-13 | Production and application of transgenic mushroom mycelium and fruitbodies |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0708826A1 (en) |
| AU (1) | AU682057B2 (en) |
| CA (1) | CA2167152A1 (en) |
| WO (1) | WO1995002691A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998021975A1 (en) * | 1995-02-09 | 1998-05-28 | Amycel, Inc. | Mushroom caps with reduced scaling |
| WO1996041882A1 (en) * | 1995-06-12 | 1996-12-27 | Proefstation Voor De Champignoncultuur | Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof |
| EP1409693B1 (en) | 2000-06-28 | 2008-03-26 | The Penn State Research Foundation | Method for transformation of agaricus bisporus |
| WO2007111500A1 (en) * | 2006-03-27 | 2007-10-04 | Plant Research International B.V. | Immunization with transgenic mushrooms |
| US7973215B2 (en) | 2008-04-11 | 2011-07-05 | Mycomagic Biotechnology Co., Ltd. | Method for the introduction of a heterologous polynucleotide into a mushroom |
| US8907165B2 (en) | 2009-04-22 | 2014-12-09 | Medicine In Need Corporation | Production of provitamin A carotenoids in mushrooms and uses thereof |
| US8686218B2 (en) | 2010-04-14 | 2014-04-01 | The Penn State Research Foundation | Strategies for the transgenic manipulation of filamentous fungi |
| CN110295161B (en) * | 2019-07-16 | 2023-08-29 | 华南农业大学 | Protoplast fusion method of tricholoma giganteum and agaricus bisporus |
| CN110714094B (en) * | 2019-11-22 | 2022-06-03 | 福建农林大学 | SCAR molecular marker for specifically identifying tremella strain and identification method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996390A (en) * | 1989-01-19 | 1991-02-26 | Campbell Soup Company | Novel interspecific mushroom strains |
| DE69331121T2 (en) * | 1992-03-09 | 2002-07-11 | Oji Paper Co., Ltd. | Ornithine carbamoyl transferase gene and its use as a gene marker in an expression system for the production of proteins in Basidiomycetes |
-
1994
- 1994-07-13 WO PCT/NL1994/000164 patent/WO1995002691A2/en not_active Application Discontinuation
- 1994-07-13 EP EP94925030A patent/EP0708826A1/en not_active Ceased
- 1994-07-13 CA CA002167152A patent/CA2167152A1/en not_active Abandoned
- 1994-07-13 AU AU75091/94A patent/AU682057B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995002691A2 (en) | 1995-01-26 |
| WO1995002691A3 (en) | 1995-03-09 |
| CA2167152A1 (en) | 1995-01-26 |
| AU682057B2 (en) | 1997-09-18 |
| EP0708826A1 (en) | 1996-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zwiers et al. | Efficient Agrobacterium tumefaciens-mediated gene disruption in the phytopathogen Mycosphaerella graminicola | |
| Rambosek et al. | Recombinant DNA in filamentous fungi: progress and prospects | |
| Daboussi et al. | Transformation of seven species of filamentous fungi using the nitrate reductase gene of Aspergillus nidulans | |
| Sullivan et al. | Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast | |
| JP4307563B2 (en) | Agrobacterium-mediated transformation of filamentous fungi, especially those belonging to the genus Aspergillus | |
| Grewal et al. | A recombinationally repressed region between mat2 and mat3 loci shares homology to centromeric repeats and regulates directionality of mating-type switching in fission yeast | |
| Judelson et al. | Transformation of the oomycete pathogen, Phytophthora infestans | |
| Peberdy | Protoplast fusion—a tool for genetic manipulation and breeding in industrial microorganisms | |
| Dufresne et al. | clk1, a serine/threonine protein kinase-encoding gene, is involved in pathogenicity of Colletotrichum lindemuthianum on common bean | |
| Yu et al. | Identification of pathogenicity-related genes in the rice pathogen Ustilaginoidea virens through random insertional mutagenesis | |
| Talhinhas et al. | Agrobacterium-mediated transformation and insertional mutagenesis in Colletotrichum acutatum for investigating varied pathogenicity lifestyles | |
| US4816405A (en) | Vectors for transformation by ascomycetes | |
| Koltin | The killer system of Ustilago maydis: secreted polypeptides encoded by viruses | |
| CN112410234B (en) | Visual screening method for multi-target editing recombinant aspergillus strains | |
| AU682057B2 (en) | Production and application of transgenic mushroom mycelium and fruitbodies | |
| Lichter et al. | Fil1, a G-protein α-subunit that acts upstream of cAMP and is essential for dimorphic switching in haploid cells of Ustilago hordei | |
| Wilson et al. | The novel Huntiella omanensis mating gene, MAT1-2-7, is essential for ascomatal maturation | |
| Petersen et al. | Structural heterozygosis at genes IL V2 and IL V5 in Saccharomyces carlsbergensiss | |
| Rose et al. | A decarboxylase encoded at the Cochliobolus heterostrophus translocation-associated Tox1B locus is required for polyketide (T-toxin) biosynthesis and high virulence on T-cytoplasm maize | |
| Beckerich et al. | Yeasts | |
| Picknett et al. | Development of a gene transfer system for Penicillium chrysogenum | |
| JP5483001B2 (en) | Method for mating incompetent filamentous fungi | |
| Passer et al. | Obligate sexual reproduction of a homothallic fungus closely related to the Cryptococcus pathogenic species complex | |
| JPS62501885A (en) | Vector-based fungal transformation method | |
| Alic et al. | Genetics and molecular biology of the lignin-degrading basidiomycete Phanerochaete chrysosporium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |